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The dimensions of microfluidic devices closely parallel those of biological cells; 
thusly, they are excellent platforms for the speciation, transport, manipulation, and 
analysis of cells. Electrokinetic transport of Escherichia coli and Saccharomyces 
cerevisiae was evaluated in microfluidic devices fabricated in pristine and UV-modified 
poly(methylmethacrylate) and polycarbonate. The magnitude and direction of transport 
of the cells was dictated by the buffer composition, conduit surface chemistry, and 
intrinsic cellular electrical properties. Baker’s yeast in all devices migrated toward the 
cathode, because of their smaller electrophoretic mobility compared to the 
electroosmotic flow of the polymer. E. coli cells suspended in 20 mM PBS migrated 
toward the anode, which indicated that the apparent mobility of the E. coli cells changed 
direction at higher ionic strengths. The observed differential migrations were exploited to 
sort cells, whereby judicious choice of the buffer concentration and the polymeric 
material in which the cell sorting was performed was controlled, allowed for cell 
enumeration via laser-based backscatter signals.  
A novel microfluidic device that selectively and specifically isolated the exceedingly 
small numbers of circulating tumor cells (CTCs) from whole blood through a monoclonal 
antibody (mAB) mediated process by sampling large input volumes (≥1 mL) of whole 
blood directly in short time periods (<37 min) was designed, manufactured and 
implemented. Upon processing, the CTCs were concentrated into small volumes (190 
nL) and the number of cells captured were read without the need for labeling by using 
an integrated conductivity sensor following an enzyme mediated release of the captured 
CTCs from the microchannel surface. The microchannel walls were covalently 
decorated with mABs directed toward breast cancer cells that over-express epithelial 
xviii 
 
cell adhesion molecules. The released CTCs were then enumerated on-device using 
conductivity detection with 100% detection efficiency and exquisite specificity for CTCs. 
The CTC capture efficiency was made highly quantitative (>97%) by designing capture 
channels with the appropriate widths and heights. Extension of the technique to 
environmental samples was performed using analogously patterned polyclonal anti-E. 
coli O157:H7 antibodies directed towards the virolent bacterial strain were used to 
isolate the enterohemorrhagic bacteria while E. coli K12 were not adsorbed to the 




I.1 Origins of Life 
The biological cell is the most fundamental of organisms that embody life processes. 
Individually these small wonders can be considered the manufacturing facilities from 
which all biological processes find their origins.1 On a grandiose scale the full gambit of 
all known biological cells can be classified as one of two major classes: (i) prokaryotic or 
(ii) eukaryotic. The root, Karyotic refers to the nucleus or control center of the cell. The 
nucleus is enclosed by a sub-membrane within the primary cellular envelope yet 
separated from it by the cytoplasm. “Eu”, from the Greek, means true and from this one 
can surmise that the eukaryotic cell possesses a nucleus and conversely the 
prokaryotic cell does not.  
I.2 Cell Biology: Prokaryotes and Eukaryotes 
In this dissertation, I focus on cells originating from the Monera and Anamalia 
Kingdoms, primarily owing to the clinical, environmental, and medical information that 
can be ascertained from the cellular contents. Clinicians are actively pursuing means of 
isolating, quantitating, and subsequently examining these cells due in part to toxic, 
virulent, and pathogenic potentials possessed by the various cell types.2-4 
Morphologically, prokaryotes are smaller and less complicated cells typically 5 μm in 
diameter or smaller with an outer membrane that is composed of a phospholipid bilayer 
that encompasses a cytoplasm and nucleoid rather than a nucleus.5,6 In this cell type 
there exists a high probability of finding genetic materials in the nucleoid.6 It is widely 
held in the scientific community that the initial prokaryotes through a series of symbiotic 
processes took up residence within the early eukaryotic cells significantly increasing 
their complexity during the evolutionary cycle.6,7 Specifically, plastids8 and 
mitochondria9 are cited as originating as free-living prokaryotes that found shelter within 
primitive eukaryotic cells.6 As evidenced by the present form of eukaryotes, these 
moieties eventually became stabilized as permanent symbiotic elements within 






Figure I.1 Illustration of the DNA forming a double helical structure with an expansion of 






I.3 Molecular Biology 
I.3.1 Nucleic Acids. A molecule of deoxyribonucleic acid is composed of a series of 
smaller subunits. DNA primarily consists of two polymer chains of deoxyribonucleotides 
that are bound by a hydrogen bonding between each pair of complementary bases. 
Each nucleotide base exists as a separate unit having its own deoxyribose residue and 
a phosphate group. Figure I.1 illustrates the deoxyribose sugar unit and the four 
nucleosides. The four nucleic acids (nucleosides) are grouped into two classes of 
molecules, pyrimidines and purines. Adenine and guanine are purines that have an 
imidazole ring fused to the pyrimidine ring. Cytosine and thymine are pyrimidines having 
a basic six member ring structure with two nitrogens at the 1 and 3 positions.1  
The nucleosides along with a deoxyribose sugar unit through a Β-N-glycoside bond 
between the first carbon C1 of the sugar unit and either the first nitrogen group N1 of the 
pyrimidines or the N9 group of purines in conjunction with the hydroxyl group at the C5 
(5’-carbon) position can be converted to a phosphate ester, at which point the three 
units together form a deoxyribonucleotide (nucleotides). Analogous units then link to 
form a polymer chain via phosphodiester linkages between the C5 phosphate ester and 
the C3 group (3’- carbon) of the next deoxyribonucleotide unit. In this manner, the 
molecule forms through a backbone or a continuous linkage of C5 – C3 (5’→3’) 
phosphodiester linkages. The end of the linear polymer having no nucleotide linked to 
the 5’-carbon is said to be the 5’-end while the opposite end, which has no residue at 
the 3’-carbon, is said to be the 3’-end. This labeling lends itself to some directionality in 
reading the chain from one terminus to the other, with the forward direction always 
denoted as 5’→3’.1  
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DNA acquires its double helical shape from the bonding of the nucleotide bases from 
one chain with those of the other. In a molecule of DNA, the two linear polynucleotide 
chains are oriented anti-parallel to each other as demonstrated in Figure I.1, with one 
chain oriented in the 5’→3’ direction, and the anti-parallel chain in the 3’→5’ (reverse 
direction). The ordering of the nucleotide bases from the 5’-chain is complementary to 
the order of the bases in the 3’-chain. If a planar structure of the molecule is imagined, it 
would be similar to a ladder, with the nucleotide bases forming the steps, and the sugar-
phosphate backbone holding the steps together. The helical formation is partly the 
result of the simple hydrogen bonding between the nucleotide bases. Based on their 
structures and the specific binding affinity of each, it is noticed that guanine and 
cytosine are bound through three hydrogen bonds, while adenine and thymine are 
bonded through two hydrogen bonds; the double helix is achieved specifically from this 
purine:pyrimidine pairing. Other pairing possibilities are strictly forbidden. Guanine-
thymine and adenine-cytosine bonds would result in mismatches because the pattern of 
hydrogen acceptors and donors do not correspond. The close proximity of guanine-
adenine (purine) molecules bound together is energetically unfavorable, while thymine-
cytosine (pyrimidine) bonds are energetically unfavorable since the molecules would be 
too far apart for hydrogen bonding.1 
I.3.2 Genetic Link to Tumor Development. Within the DNA are regions (~1%) 
responsible for coding proteins.10 Some genes can be correlated to physical traits such 
as eye or hair color while other genes with specific combinations of errors are correlated 
with proliferative unregulated cell growth that can result in the development of a genetic 
disorder termed cancer. In particular, this type of gene is referred to as an oncogene. 
During early developmental stages of a neoplasm cells with an inherent resistance to 
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apoptosis, programmed cell death, have the potential to multiply at alarming rates. 
These cells typically have many cell adhesion molecules decorating their periphery and 
as a result these cells tend to aggregate forming the tissue that is ultimately referred to 
as a tumor. In order for tumorigenesis to occur tumors require vascularization to thrive, 
because oxygen and other blood borne necessities such as divalent cations are 
necessary components for tumor survival. 
I.4 Circulating Tumor Cells 
Circulating tumor cells (CTCs) occur with exceedingly low frequency within the 
peripheral blood matrix, as a result these cells are rare comprising as few as one cell 
per 109 haematologic cells in the blood of a patient with metastatic disease; thereby, 
indicating the tremendous technical challenges of attempts to isolate and enumerate 
CTCs. Microfluidic cell handling devices provide seemingly ideal platforms for speciating 
these events and moderate successes have been yielded in microfluidic flow 
cytometry,11,12 continuous size based separation,13-15 and even chromatographic 
separations.16 The essential parameters that determine efficiency of cell capture on a 
microfluidic platform are: 1) flow velocity, because it dictates residence times;17 2) 
throughput, because rare events require processing large samples;18 and 3) collision 
probability, because the cells must interact with the walls in order for a binding event to 
occur.18  
CTCs originate from primary neoplastic sites and are subsequently disseminated 
into the circulatory system and transported by the peripheral blood through a 
multivariate process termed the “metastatic cascade”. The metastatic cascade is 
referred to as a series of well defined interdependent events leading to a clinically 
relevant overt lesion.19 The single most relevant prognostic factor in epithelial derived 
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tumors is the metastatic infiltration of distant organs. For example, in International Union 
against Cancer (UICC) stage II colon cancer patients with locally limited tumor 
progression have survival rates of 75% contrasted with only 13% for UICC stage IV 
patients who have evidenced distant organ metastasis.20 In an analogous manner, in 
the much more heterogeneous breast cancer diseases the metastatic spread has the 
most important impact on the patient’s outcome.21 Further, metastatic evidence in the 
blood and/or bone marrow is also indicative of prognostic impact.22 Triggering the 
cascade is a process called the epithelial-mesenchymal transition (EMT). This 
phenomenon enables otherwise stationary epithelial cells to migrate causing invasion 
into surrounding tissues eventually resulting in the detachment of neighboring cells and 
release into in the microenvironment. The scheme for this process is not completely 
understood; however, several integral components have been identified such as the 
receptor tyrosine kinase, growth factors, GTPases, and integrins that are closely 
associated with cell adhesion and migration.23-25 
I.4.1 Natural Defense from Proliferation Metastasis. The process of hematogenous 
transport of the disseminated cells is an inherently destructive process that’s considered 
the first line of defense against metastatic disease.26 From the onset of tumorigenesis 
CTCs can be released from the very small micrometer scale tumors. Upon being shed, 
the CTCs are fragile and lack interactions with blood borne fibrin and platelets, and as a 
result the membrane can be easily destroyed by sheer stress imparted by blood flow.26 
In addition, natural killer cells termed Pit cells27 and Kupffer cells28 attack the neoplastic 
cells immediately upon release.29 Presence of the CTC in the peripheral blood triggers 
as much as an 80% increase in the number of natural killer cells within the peripheral 
blood in a matter of minutes. Most tumor cells subject to hematogenous transport are 
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either mechanically destroyed from the sheer stress of blood flow rupturing the cells 
membrane or the CTC undergoes a process called anoikis, a special form of cell death 
resulting from an adhesion deficiency. The vast majority of the carcinoma cells are killed 
within a few hours of dissemination through the natural defense systems, thereby 
demonstrating the relatively low efficiency of metastatic events.30 
I.4.2 Metastatic Tumor Progression. Cancers that originate in organs such as the 
mammary glands, colon, and/or prostate are forms of adenocarcinomas. Most often, 
tumors develop in the organs proximal to capillary beds, owing in part to the metastatic 
CTC surviving the natural protections provided by the circulatory system. This survival is 
further supported by the CTC developing a protective barrier consisting of fibrin and 
platelets sufficient to prevent lysis from blood flow related sheer stress by providing 
stabilizing reinforcement, and barrier like protective coating from natural killer cells. 
Subsequently, the surviving CTCs are arrested in capillary beds in which adhesion 
molecules of the distant organ act on receptors in the CTC membrane forming 
complexes. Aiding this process is the relatively narrow bore of the capillaries resulting in 
increasing the probability of adhesion, based on the CTCs and receptors being 
proximally within binding range of the adhesive molecules on the surface for extended 
periods due to decreased mobility. Subsequently, extravasation results when the tumor 
cells migrate across the capillary wall. The morphology of cancer cells is distinct, these 
cells are often larger (15 – 40 μm dia.) than normal haematopoetic cells and they harbor 
above average sized nuclei.31 
I.5 Human Concerns 
Cumulatively, cancer is the leading cause of death among the world population and 




environmental, occupational, and/or hereditary factors.32 Though no point source can be 
cited in most cancer cases, all cancers stem from specific sets of combinations of 
defects in the genetic code.1,26 In many cases even this is obscure and not well 
understood. These defects can be caused by insertion, deletion, or substitution of bases 
in the genes resulting in producing proteins that have markedly different behaviors.1,26 
As a result, CTCs are of interest to researchers, because they can provide insight into 
disease states, and when quantified they can provide both valuable prognostic and 
diagnostic information about patients.33 
I.6 Environmental Concerns 
Some prokaryotes, though indigenous to humans and animals that humans 
consume can be toxic and potentially lethal.34 The number of cells required for such an 
outcome varies, but is contingent upon the nature of cell at issue. As an example as few 
as 10 Escherichia coli 0157:H7, an enterohemorrhagic bacterium, can proliferate in the 
digestive system causing Shigella dysentery, a potentially fatal disease if not 
treated.35,36 Conversely, a benign strain (K12) of bacteria of similar origin that of the 
0157:H7 variety is harmless.37 Morphologically these two strains are identical, but they 
express markedly different proteins due to differences in their DNA. The toxic strain 
produces shiga-like toxins referred to as SLT-I and SLT-II.38 These bacteria are 
indigenous to the gut of bovine animals, and can be isolated from pastures containing 
feces from the animals. Through precipitation and subsequent runoff these dangerous 
cells work their way into the water table impacting ground water and aquifers.39 
Maintaining safe recreational areas, fisheries, and drinking water is contingent upon 
being able to readily identify and quantitate the contaminants on site. 
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I.7 Research Focus: Need for Greater Selectivity, Sensitivity, and Portability 
In this dissertation, I investigate the use of surface modification chemistries and 
electrokinetic pumping in polymer-based microfluidic devices as a means of controlling 
the rate and direction of movement of cells in suspension. I also present data from the 
hydrodynamic manipulation of cells in analogous devices. The need for sensitive 
selective methods to isolate, enumerate, and phenotype low abundant biological cells is 
apparent whether the need arises as a result of United States of America Environmental 
Protection Agency USEPA mandates on water quality or if the need is in the clinical 
setting at the point of care there exists a need for rapid approaches to selectively 
speciate and evaluate particular cells from often complex matrices i.e. peripheral blood. 
Nagrath et al. recently presented a device capable of selecting rare cancer cells, but to 
date, no methodologies presented completely satisfies clinical need.17 I present a novel 
approaches toward real solutions to these problems.  
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Biological cells have been of interest to researchers performing bioassays since the 
imaging of the first cell by Anton von Leeuwenhoek in 1674.1 About two centuries later, 
Ashworth observed an atypical cell type in the peripheral blood that morphologically 
appeared to be of epithelial origin and was designated as a tumor cell.2 Since then, 
isolating and enumerating circulating tumor cells based on phenotype has been of 
interest in many basic, clinical, and medical research settings. The challenge with using 
circulating tumor cells present in peripheral blood, or other clinical samples, as a cancer 
diagnostic marker is the extremely low frequency in which these cells appear in relative 
to other cell types. For example, it is not uncommon to find 5 – 10 tumor cells in 1 mL of 
whole blood that also contains 107 red blood cells (erythrocytes, RBCs) and 103 white 
blood cells (leukocytes, WBCs). Therefore, enrichment factors exceeding 107 must be 
obtainable by the equipment used to select and subsequently enumerate these cells. 
Unfortunately, cancer cells will proliferate due to the cells’ lack of appropriate cues 
for apoptotic or programmed cell death resulting from a combination of genetic defects, 
which inevitably provides their ability to survive circulation and adhere to secondary 
sites giving rise to metastatic disease.3 As a matter of definition, neoplastic cells 
originating from a primary site are often referred to as tumor cells.4 The term “tumor cell” 
can be applied to both benign and malignant varieties of neoplastic cells; however, only 
malignant cells are aptly termed “cancer cells”.  As such, circulating tumor cells (CTCs) 
can or will not spawn metastatic disease depending upon their genetic makeup.   
Morphologically, tumor cells are typically smaller than normal epithelial cells and 
they possess larger nuclei with small cytoplasmic regions (see Figure 1.1). These 
morphological differences make them easy to differentiate with respect to normal 
epithelial cells, which typically do not appear in peripheral blood.5 The characteristic 
features of cancer cells’ morphology has been linked in part to the pentose phosphate 





Figure 1.1 Micrographs of (A) normal epithelial cells and (B) malignant epithelial tumor 
cells. Note the larger size of the normal epithelial cells compared to the tumor cells. 




Besides morphological differences, the molecular composition of tumor or cancer 
cells substantially differs from that of normal epithelial cells as well. Many cancers are 
characterized by mutations within the genome of tumor/cancer cells that can give rise to 
gene silencing or gene hyperactivity resulting in the over-expression of various 
molecular entities, such as integral membrane proteins. For example, many 
adenomacarinomas over-express the epithelial cell adhesion molecule (EpCAM),7 or in 
the case of prostate cancer, the prostate specific membrane antigen (PSMA).8   
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Metastasized epithelial cells undergoing hematogenous transport are atypical in 
healthy human blood.9  However, many adenocarcinomas are characterized by tumor 
cells shed from the primary tumor site into the peripheral blood.  As noted above, the 
number of these cells in the peripheral blood is extremely low compared to the RBC and 
WBC count.  For example, the number of tumor cells from breast cancer patients can be 
in the range of 5 per mL of whole blood.10  
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Figure 1.2 Processing time as a function of the fluidic cross-section using microfluidics 
at three different linear velocities. The total volume sampled is 1.0 mL. Note the 35 × 
150 μm2 cross-section indicated in the figure for a single or 51 parallel channels.  These 







The predominate techniques used to select rare tumor cells from peripheral blood or 
other biological/clinical samples has been carried out using fluorescence assisted cell 
sorting (FACS) or magnetic assisted cell sorting (MACS);11,12 the complexity of 
FACS/MACS instrumentation and the required operator expertise makes these 
techniques prohibitive toward their widespread adoption for screening applications, 
which has facilitated a strong interest in producing simpler and more efficient methods 
for sorting and the subsequent enumeration of these rare cells.13  
For sampling rare events, four important metrics must be assessed: i) throughput, 
the number of cell identification or sorting steps per unit time; ii) recovery, an indicator of 
the fraction of target cells collected from the input sample; iii) purity, which depends on 
the number of “interfering” cells excluded from the analysis; and iv) analysis time, which 
is the time it takes to process a specified volume of sample exhaustively.14  In addition 
to these metrics, highly efficient quantification of the number of enriched cells must be 
provided as well.  
Throughput is directly proportional to the cross-sectional area of the conduit through 
which the sample is delivered and the sample volume required for interrogation (see 
Figure 1.2). The input sample volume required for the assay is determined by the 
frequency of cell appearance in the sample.  At 5 cells mL-1, a sampling volume of 1 µL 
would produce a probability of finding the cell in that volume of only 0.5%. Because 
CTCs are of low frequency (1 – 10 cells mL-1), high volume sampling (≥1 mL) is required 
to increase the probability of isolating these rare events. If the cross-sectional 
dimensions of 35 x 35 µm are employed to exhaustively search for rare cellular events 
when the transport rate is 10 mm s-1, and an input volume of 1.0 mL is required, the 
sampling time would be approximately 278 h. For cell sorters consisting of a single 
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rectangular via with dimensions of 150 × 35 µm under similar conditions the sampling 
time would reduced to approximately 5.6 h.  However, if the 150 × 35 µm conduit were 
highly parallelized by incorporating 51 vias, the processing time drops to 0.12 h as 
shown in Figure 1.2. The time it takes to process 1.0 mL of fluid at varying linear 
velocities for channels with different cross sectional areas are also shown in Figure 1.2. 
As can be seen, increases in the linear transport rate does affect the processing time, 
with higher transport rates reducing the processing time. 
The purity of the enriched targets is also critical, because impurities can result in the 
generation of false positives. For molecular recognition used for cell selection, the level 
of purity is predicated on the specificity of the recognition element used for its binding 
partner. For size-based selection, cells with sizes similar to the target cells can provide 
potential interferences.  For example, recovery rates using size selection can typically 
be on the order of 60%, but are often marred by interferences resulting in low purity 
enrichments caused by contaminating leukocytes due to the similarity in sizes of the 
WBCs and tumor cells.15-19 Attempts to further pre-concentrate the targets and remove 
potential WBC interferences introduce a significant risk of target loss.15,20  
There exist two extremes pertaining to the habitat of the target cell. One extreme is 
that of a relatively simple sample matrix containing few cell-like constituents that would 
potentially interfere. At the other extreme is whole blood; 40 – 57 (w/w)% of normal 
peripheral blood from a healthy person consists of suspended solids in the form of 
leukocytes and erythrocytes.21 For this reason, analyzing blood directly has presented 
several distinct challenges requiring in most cases, various types of sample 
pretreatment prior to the cell sorting. These pre-treatments range from serial dilution (up 
to 10-fold)22 to density gradient centrifugation,23 whereby particles with distinct mass-to-
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volume ratios are separated into layers of varying density [40 – 70%(w/w)] in a 
cushioning medium via centrifugal force.24 Initially, layers of varying concentrations of 
sucrose are added to a vessel with the least dense layer being added first with 
subsequent layers with increasing densities being added above the seed layer. The last 
layer added to the vessel contains the sample suspension with the target cells. 
Depending on particle density, a centrifugal force of as much as 150,000×g is applied to 
the sample using ultracentrifugation resulting in all constituents originating in the sample 
residing in the layer of solution that matches the density of the respective particles. 
Layers containing the targets are harvested by recovery with a pipette. These 
techniques typically provide 70 – 90% target cell recovery.25 In terms of whole blood, 
density gradient centrifugation is used to remove the RBC fraction of whole blood, 
leaving only the mononucleated fraction for cell selection of the targets. 
There are fundamentally two different device formats that can be used for selecting 
rare cells from mixed populations, macro-scale systems and micro-scale systems.  
Macro-scale systems are attractive for selecting rare cells due to their ability to process 
large input volumes easily while conventional microsystems do not possess the ability to 
process large input volumes as easily (see Figure 1.1), which is required to generate a 
high statistical confidence for successfully securing the rare cells from the processed 
sample. 
1.2 Transport Phenomena 
 Blood is a uniquely complex fluid composed of deformable cells suspended in an 
aqueous liquid that contains many proteins, lipids, and other colloids. Blood averages 
48% blood cells by weight with greater than 95% of the cells being erythrocytes. Blood 
exhibits non-Newtonian rheological characteristics unrelated to coagulation or clotting 
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as the apparent viscosity decreases with increasing shear rate; as blood flows more 
quickly the apparent viscosity decreases, an effect known as shear thinning.26 
Manipulating viscous samples containing cellular targets in fluidic vias, most commonly 
microfluidic vias, can be accomplished by establishing a pressure differential or by 
initiating an electrokinetic flow characterized by either a parabolic or flat profile, 
respectively.  
1.2.1 Electrokinetic Pumping. Glass and fused silica-based substrates have been 
used extensively in microfluidics for performing bioassays due to its well defined surface 
chemistry.27  The presence of these surface silanols in glass and fused silica generates 
a movement of the bulk solution when an electric field is applied to the fluidic conduit 
that moves from the anode to the cathode.28-32 This transport phenomenon is due to the 
electroosmotic flow (EOF). EOF is brought about when the negatively charged surface 
that results from the deprotonation of silanols attracts cations forming both a fixed and 
diffuse mobile layer. The immobile layer is closest to the wall, and adjacent to positive 
ions separated by a plane of shear. The potential difference across this plane is termed 
the zeta potential. The zeta potential (ζ) is given by: 
ζ = 4πδe/є (1) 
where δ is the double layer thickness, e is the charge per unit surface area, and є is the 
dielectric constant of the buffer. The mobile layer is carried towards the cathode under 
applied electric fields dragging the bulk solution along with it. The magnitude of the EOF 
in glass is typically greater than the electrophoretic mobility of most analytes. The EOF 
ultimately leads to migration of all positive, neutral, and negative charged components 
towards the cathode in that respective order. This type of pumping is typically not ideal 
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for high fluid throughput fluid processing due to its potential for developing voids within 
the buffer resulting from O2 and H2 evolution at the electrodes.33,34 
While glass and fused silica have relatively large EOF values at high pH values, the 
situation for polymer-based materials is ill-defined. Different polymeric material as well 
as the treatment imposed on those materials can dramatically affect the surface 
chemistry and therefore, produce significant variations in the EOF.  In addition, 
decreases in the number density of ionizable surface groups results in significantly 
lower EOFs in polymers relative to glass-like materials.24,35  
Our research group has successfully overcome this obstacle by applying chemistries 
for surface modification of poly(methyl methacrylate), PMMA, and polycarbonate, PC.35-
38  The potential exists to photo-oxidize polymer surfaces by UV exposure, which result 
in increased EOFs due to increases in the surface charge density, while not disturbing 
the integrity of the bulk polymer.36,37,39 The formation of phenyl salicylates and 
hydroxybenzophenones as well as other hydroxyl and keto containing groups result on 
the surface of UV irradiated PC. UV irradiation induces photo-oxidation at the surface of 
PMMA forming hydroxyl functional groups.37 
Witek et al. reported on the use of polymeric microfluidics for the electrokinetic 
transport of E. coli and S. cerevisiae to examine the effects of surface chemistry on the 
apparent mobility for pristine and UV modified poly(methylmethacrylate) and 
polycarbonate microdevices at varying ionic strengths.33 The electrokinetic transport of 
differing cell types was presented in which the potential for separating cells based on 
their intrinsic electrical properties was discussed. The magnitude and direction of the 
apparent mobilities were determined. The fastest electromigration was exhibited by S. 
cerevisiae in a 0.5 mM PBS buffer in a UV-modified microchannel with an apparent 
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mobility reported to be 4.83 ± 0.80 × 104 cm2 V-1 s-1, and a velocity of E. coli in pristine 
PMMA equal to -1.04 ± 0.04 × 104 cm2 V-1 s-1. 
1.2.2 Hydrodynamic Pumping. Hydrodynamic pumping results from a pressure 
differential and is characterized by a parabolic profile and this type of pumping is 
prevalent in high throughput applications owing in part to the ability of mechanical 
pumps to deliver fluids at well regulated flow rates into high head pressure conduits. In 
addition, all material move in one direction irrespective of their chemical composition.  
Another problem avoided by hydrodynamic pumping is Joule heating, which results from 
resistive heating of the buffer due to current flow and poor heat dissipation. However, 
hydrodynamic transport generates large pressure drops for long conduits with small 
inner diameters. The pressure drop is directly proportional to the length of the conduit, 
flow rate of the solution, and the kinematic viscosity of the solution. The pressure drop 
(∆P) across any conduit can be determined using Poiseuille’s Law:  
∆P = 8LQη/πR4 (2) 
where L is the length of the conduit, Q is the flow rate of the fluid, η is the kinematic 
viscosity of the fluid, and R is the conduit radius. From Poiseuille’s equation, it can be 
seen that the radius has an inverse exponential effect on ∆P. As an example of the 
throughput potential afforded by hydrodynamic pumping, Adams et al. demonstrated the 
ability to hydrodynamically process solutions through a micro-conduit at velocities as 
high as 100 mm s-1 with no device failure due to the high pressure drop generated 
under these conditions.24 
1.3 Composition of Microfluidic Devices 
In the production of microdevices for any particular application, the fabrication 
technique required by the material and the associated cost of the material has to be 
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considered. For example, when considering clinical assays, sterile materials are 
required for each assay and the ability to use the same device for multiple samples is 
not possible due to carryover artifacts. Therefore, low-cost and easy manufacturable 
devices are ideal. As a result, polymers are attractive substrates because replication-
based processes can be used to mass produce devices at low-cost. 
Various applications require alternative substrate material.  In choosing materials for 
microfluidic devices, the following should be considered; (i) thermal and electrical 
properties, (ii) analyte and matrix chemical compatibility, (iii) availability in pure form at 
an affordable cost, (iv) excellent optical properties in the measurement range, (v) 
amenable to surface functionalization, (vi) applicable to mass-production using simple 
fabrication techniques and (vii) the fabrication technique can produce the requisite 
structures for the intended application. 
There exist significant cost advantages associated with polymeric microfluidics using 
currently available techniques that involve the production of a metal mould with positive 
relief structures that can be used to produce structures within a polymeric material. 
Commonly used techniques for producing parts from metal moulds include casting, hot-
embossing, and injection moulding. 
1.3.1 Polymeric Substrates. Hot embossing and injection moulding are common 
modalities for producing polymeric micro-parts and can produce fluidic layouts with high 
aspect ratio microstructures (HARMS).39  Details of hot embossing and injection 
moulding are discussed in detail elsewhere.40-42 Briefly, hot embossing involves the 
transfer of a positive structure, termed a mould insert/master, to a substrate under 
precisely controlled temperature and pressure. The substrate is typically heated to 
above the glass transition (Tg) temperature of the polymer, and an applied force in the 
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range of several thousand Newtons. The Tg of a polymer indicates the temperature at 
which the polymer begins to flow due to the thermally initiated breaking of non-covalent 
bonds between the polymer chains. The application of significant force ensures that the 
polymer fills the mould cavity completely facilitating the high fidelity of reproducing 
microstructures.39,43  
Conventional mold inserts are prepared via lithographic techniques that require 
radiation sources such as x-rays or UV light and electroplating to produce the mould 
master. For example, UV and/or x-ray LiGA can produce structures in the 
submicrometer regime with aspect ratios exceeding 20 or more, but involves 10 – 14 
steps to go from concept to final product (see Table 1.1).42 Alternatives, such as high 
precision micromilling, has fewer processing steps but can only produce structures with 
lateral dimensions on the order of 20 µm and aspect ratios of 5. However, mould 
fabrication only requires a few processing steps. 
 
Table 1.1 Comparisons of Manufacturing Techniques for Microfabrication. 
Characteristics  LiGA – X-ray LiGA – UV   Micromilling  
Minimum size  20 nm  500 nm  20 μm  
Multilevel 1 3 or less 5 or less 
Aspect ratio  100 or more 20 or less 5 or less 
Side-wall roughness 1-10 nm 20-50 nm >150 nm 
Production cost  $$$ $$ $ 
Processing steps 14 steps 10 steps 4 steps 




In contrast to glass-based microdevices, polymeric microdevices have relatively low 
EOF resulting from a reduction in the number density of ionizable surface groups. 
Additionally, polymers have lower occurrences of cell adhesion on pristine surfaces due 
to the low surface charge density of polymers.38  The decrease in ionizable surface 
groups results in significantly lower EOFs in polymers relative to glass-like 
materials.24,35 The apparent mobility (μapp) consists of two components: 
μapp = μEOF + μEP  (3) 
where μEOF is the mobility arising from the EOF and μEP is the mobility component 
arising from the electrophoretic mobility of the analyte. According to equation 3, the 
apparent mobility is the sum of the electrophoretic and electroosmotic mobilities. The 
EOF component is contingent upon buffer conditions and the microchannel surface 
chemistry. Our research group has generated novel surface modification chemistries of 
poly(methylmethacrylate), PMMA,  and polycarbonate, PC, to increase the number 
density of ionizable groups.35-38  The application of said surface modification chemistries 
is effective at increasing the number of ionizable surface groups, while not disturbing 
the integrity of the bulk polymer.36,37,39  
1.4 Macro-Scale Techniques for Analyzing CTCs 
 
 Macro-scale CTC techniques possess the ability to process input volumes 
exceeding ~5 mL, which is attractive due to the extremely low abundances of these cell 
types in clinical samples, The commonly used macro-scale formats for enriching CTCs 
from clinical samples include: (i) Magnetic capture using micrometer-scaled 
ferromagnetic beads coated with molecular recognition elements in macro-scale 
vessels;20,44,45 (ii) size-based separations using tracked membranes;19,46,47 (iii) flow-
assisted cell sorting;9,46,48 and (iv) reverse-transcription of mRNAs that are used as 
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chemical surrogates for tumor cell identification.49,50 Macro-scale techniques for cell 
processing and selection are typically performed using samples with volumes >1 mL. In 
the following sections, these macro-scale processing techniques for identifying the 
presence of tumor cells in clinical samples will be discussed as well as variants of these 
basic cell selection processes. 
1.4.1 Immunomagnetic Affinity Capture (IMAC). Balic et al. evaluated two 
commercially available immunomagnetic isolation kits for selecting CTCs from 
peripheral blood samples of metastatic patients.15 Both kits employed anti-epithelial cell 
adhesion molecules (EpCAM) antibodies for selecting the cancer cells. Twenty-two and 
one half mL aliquots of blood were taken from each patient with a 15 mL aliquot used 
for the OncoQuick® system and the remaining 7.5 mL used for the CellSearch® 
procedure. Both procedures employed density gradient centrifugation followed by a 
series of washes in order to remove the RBC fraction from the whole blood sample prior 
to magnetic isolation of the CTCs. Centrifugation of the RBC depleted sample was next 
performed at 800×g for 10 min to remove the blood plasma. The resulting cellular 
pellets were resuspended in 10 mL of buffer, and incubated with carboxylate-
functionalized ferromagnetic particles that were coated with anti-EpCAM. 
Immunomagnetically-labeled cells were concentrated using an external magnetic field.  
Following magnetic isolation, the processed sample was incubated with leukocyte 
specific anti-cytokeratin antibodies labeled with Alexa Fluor 555, nuclear specific 4’,6-
diamidino-2-phenylindole (DAPI), and a CTC specific anti-EpCAM antibody conjugated 
to a fluorescein derivative. Under these conditions, white blood cells and tumor cells 
harbor blue fluorescing nuclei; however, the fluorescent signatures of the FITC 
derivative selectively placed a green “halo effect” about the blue nuclei of the CTCs. 
The orange fluorescent halo from the Alexa Fluor 555 about the nuclei of the leukocytes 
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Figure 1.3 CTC recovery results from commercially available immunomagnetic cell 
isolation strategies from 61 metastatic cancer patients and 8 controls samples that were 
absent of any form of disease. Reprinted with permission.15 
 
The CTC recovery rates using both kits from cancer patients with metastatic disease 
and healthy donors are shown in Figure 1.3. Data from 53 cancer positive samples 
(Metastatic, see Figure 1.3) are shown on the left as evaluated by CellSearch and 
OncoQuick. The data indicated that the recovery of the CTCs was significantly better 





recovery). In addition, the CellSearch system required a smaller input volume compared 
to the OncoQuick system. The data for non-metastatic samples (see Figure 1.3) with 
both kits showed the detection of at least one CTC in the blood of healthy individuals in 
12% of these samples analyzed. For the confirmed metastatic cancer cases, CellSearch 
was capable of producing positive responses in 54% of these samples resulting in a 
relatively high rate of false negatives.48 The OncoQuick system demonstrated poorer 
detection accuracy as only 23% of the samples were reported positive for metastatic 
disease. In 5 of the 6 varieties of cancer studied, CellSearch was twice as effective as 
OncoQuick at detecting metastatic disease and CellSearch was also found to be more 
sensitive in common positive tests often identifying more CTCs within similar amounts 
of peripheral blood. 
1.4.2 Sized-Based Separations. Tracked polycarbonate membranes with varying pore 
sizes (8 – 14 µm) have also been employed to filter large (9.0 – 18 mL) blood samples 
spiked with known quantities of CTCs.51 Prior to filtration using the membrane, the 
samples were diluted at a 1:1 (v/v) ratio of spiked blood:PBS containing an 
anticoagulant (ethylene diamine tetra acetic acid). Simple gravimetric filtration through 
these polycarbonate membranes is sufficient to reduce the erythrocyte content by >105 
cells mL-1. After the initial filtration using the polycarbonate filter, the isolated cells are 
washed and incubated for 1 h with anti-pan-cytokeratin directed against cytokeratin 5, 6, 
8, 17 and 19)-FITC. After a wash to remove the unbound anti-cytokeratin antibodies, 
nuclei-specific propidium iodide is added, and an additional incubation of 30 min 
performed. The cells retained by the polycarbonate membrane are analyzed using a 
combination of laser scanning cytometry (LSC) and microscopy. After analysis, all the 




positive events. Only positive cells with the appropriate nuclear:cytoplasmic ratio were 
counted as positive events. False positives were evident in the case of MCF-7 cells, and 
the authors attributed this to the presence of adhesion molecules on the cells’ periphery. 
The most prominent reduction in leukocyte frequency was demonstrated for 9 mL blood 
samples that originally contained 50,000,000 leukocytes, which was reduced to 7,000 
leukocytes after the filtration step. These membranes were demonstrated to isolate 
nearly 85 – 100% of the CTCs, but significant numbers of white blood cells were also 
retained due to their similar size with respect to the CTCs complicating the enumeration 
process. Also, the process requires pre or post treatment of retained cells with a variety 
of fluorescent stains before the LSC could be utilized. 
Microarrays have also been used in the isolation of target cells. Various “cluster of 
differentiation” (CD) antigens are affinity-captured onto the arrays containing 
immobilized antibodies.52 The arrays contain several surface-immobilized antibodies 
directed toward target antigenic species, which are used to spatially isolate cells. These 
methods are limited by slow mass transport but are promising for multiplexed analyses; 
the array elements are not individually addressable making collecting isolated cells from 
a multiplexed analysis difficult due to the single chamber of the arrays. Most often in 
order to isolate a particular phenotype, subsequent processing is required.  Belov et 
al. presented an array technique based on cluster of differentiation in leukemia.52 The 
CD antigens could be used to phenotype leukocytes based on characteristic abnormal 
patterns of antigen expression. Microarray technology has also been used to screen 
HIV positive blood against normal as well as blood from those undergoing therapy and 
those deemed long term non-progressors.12 
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1.4.3 Fluorescence Activated Cell Sorting (FACS). Gross et al. employed FACS to 
sort spiked breast cancer cells from a BT-20 cell line that were seeded into peripheral 
blood mononucleated cells (PBMC or WBC) at frequencies of 10-5, 10-6, and 10-7.9 The 
PBMCs were suspended in PBS buffer with 20% fetal calf serum.  To the PBMC (cell 
count = 4 × 108) suspensions were added 10, 100, and 1,000 BT-20 cells. The flow 
cytometer employed three excitation sources; 325 nm, 488 nm, and 633 nm allowing for 
discrimination between the PBMCs and BT-20 cells via immunoaffinity staining. A panel 
of fluorescently-labeled antibodies specific for the PBMCs produced a green color for 
these cell types.  Another panel of immunofluorescent markers were used for the BT-20 
cells, that produced a yellow color and 2 shades of red, but no green color for these 
cells.   
 The extensive cell staining procedure is briefly listed here.  The BT-20 cells were 
stained with a blue fluorescing dye, 7-amino-4-chloromethylcoumarin (CMAC) before 
seeding these cells into a PBMC suspension. BT-20 breast cancer cells were also 
characterized by a cocktail containing three anti-cytokeratin antibodies, each tagged 
with a different colored dye. Leukocytes were identified with monoclonal antibodies 
labeled with a fourth dye.  All cells were incubated for 1 h in 150 µL of an exclusion 
staining cocktail containing 20% normal mouse serum. The following fluorescein 
isothiocyanate (FITC) conjugated antibodies were added to the suspension: 14.9 µg of 
anti-CD45 HLe1-FITC per mL; 54 µg of anti-platelet glycoprotein (gpIX) (CD42a)-FITC 
per mL; 56.6 µg of anti-pan-platelet (CD61)- FITC per mL; 2.2 µg of anti-CD34 HPCA-2-
FITC per mL; and 0.7 µg of anti-glycophorin-FITC per mL. Subsequently, a staining 
cocktail containing 25% normal mouse serum and the following anti-cytokeratin 
antibodies conjugated to peridinin chlorophyll protein (PerCP), phycoerythrin (PE) or 
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allophycocyanin (APC): 2.6 µg of NCL-5D3 anti-cytokeratin components 8 and 18 
conjugated to PerCP per mL were used; 1.8 µg of NCL-LP34 anti-cytokeratin 
components 5, 6, and 18 conjugated to PerCP per mL; 0.27 µg of CAM 5.2 anti-
cytokeratin components 8 and 18 conjugated to PE per mL; and 1.43 µg of AE1 anti-
cytokeratin components 10, 14, 15, 16, and 19 conjugated to APC per mL. The data 
were prefiltered, eliminating events negative for FITC but positive for PE, PerCP, and 
APC. In all instances the goal was to locate events characterized by fluorescence from 
FITC, PE, PerCP, and APC, which were used as positive signals for the BT-20 cells.  
 Using a color discrimination algorithm, the authors were successful at detecting rare 
BT-20 cells with 20% recovery with cancer cell frequencies of 10-5 and 10-6. However, 
the authors indicated that ~200 mL blood sample volumes would be needed to reliably 
assess rare CTCs in the presence of 108 PBMC cells at frequencies of 10-7.  The 
challenges associated with this assay format is the extensive amount of time required 
for the immunofluorescent staining (~20 h), the need for removing the RBCs from the 
blood sample prior to processing and the equipment required for the measurements.   
1.4.4 Reverse Transcription Polymerase Chain Reaction (RT-PCR). Another 
approach for the analysis of CTC presence in peripheral blood is the use of reverse-
transcription polymerase chain reaction (RT-PCR), in which mRNAs are used as 
surrogates to report on the presence of CTCs. This gene expression based assay has 
high sensitivity, but poor selectivity which leads to false positives. Often nested PCR is 
performed in which multiple rounds of the PCR amplification are performed in order to 
generate signal. Reports have documented the ability to detect low numbers of CTCs in 
106 PBMCs using an appropriate marker panel set.50 When expression profiles of 
healthy females were compared to breast cancer patients, elevated median levels of 
three of the markers comprising this panel (p1B, PS2, CK19, and EGP2) were found 
(see Figure 1.4).  
 
 
Figure 1.4 RT-PCR expression profiling results for three genetic markers over-
expressed in tumor cells p1B (A), CK19 (B) and EGP2 (C).  In this study, 103 breast 
cancer and 96 normal patients were evaluated. The horizontal line presents the median 
expression level for each group.  In all cases, only the PBMC fraction was analyzed 
using RT-PCR.  The number of PCR cycles performed depended upon the expression 
level of each marker, but ranged from 0-50 cycles. Reprinted with permission.50 
 
 
Though RT-PCR is highly sensitive and specific when employing multiple markers in 
the expression profiling, securing morphological data on the CTCs is not possible 
because the cells are sacrificed to obtain the mRNA markers used in the assay. As with 
many CTC-based assays, the RBC fraction of the blood sample must be removed using 
for example, Ficoll-Hypaque density gradient centrifugation.  In addition, the expression 
level of the marker genes cannot be related to the absolute number of tumor cells within 
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the sample.  Finally, it has also been noted that these assays are prone to high inter-
laboratory variability.  
1.5 BioMEMS and µTAS Devices for Sorting CTCs 
Near the turn of the 21st century the concepts of biological microelectromechanical 
systems (BioMEMS) or miniaturized total analysis systems (µTAS) were introduced as a 
means of processing many biological samples, such as on-chip cell sorting.27 BioMEMS 
typically consists of several subcomponents incorporated into a single device that can 
sample, pretreat, analyze, and detect the material of interest ideally from a raw sample. 
To some extent, experiments in microdevice electrophoresis using planar substrates by 
Manz and Harrison in glass devices in the early 1990’s set forth the cascade of events 
that have resulted in advancements in the application of BioMEMS devices in the 
analysis of cells.34  
 
 
Figure 1.5 Microfabricated flow chip demonstrating directed pressure-induced cell 
manipulation. Reprinted with permission.53 
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As mentioned previously, glass and polymers have been used extensively as the 
substrate materials for BioMEMS devices; manufacturing strategies for glass or 
polymers vary greatly. Early microfluidic devices were dominated by the use of glass 
substrates, primarily because the surface chemistry of the material was well studied.35 
For BioMEMS devices, hydrodynamic,53,54 electroosmotic,55,56 and 
dielectrophoretic57,58 forces have been employed to manipulate and manage biological 
cells. Blankenstein et al. demonstrated the use of differential pressures to manipulate 
fluids into any one of five channels as shown in Figure 1.5.53 At the inlet, the sample 
was introduced into the device and conduits C1 and C2 were used to guide the sample 
to outlets 1 – 5. This work illustrated a couple interesting points: (i) directed flow could 
be achieved with simple instrumentation and (ii) fluid mixing on the micrometer scale 





Figure 1.6 Baker’s yeast cells are electrokinetically manipulated through a glass 
microdevice. Reprinted with permission.59 
Electrokinetic transport was demonstrated in glass microchips by Li et al.59 In these 
experiments, Li was able to alternate the electro-migratory path of the cells by switching 
the path of current flow resulting in a directional gate dictating the track followed by the 
cells through the glass microchips as shown in Figure 1.6. Velocities of 0.054 ± 0.005 
mm s-1 and 0.28 ± 0.05 mm s-1 were achieved at field strengths of 35 V cm-1 and 140 V 
cm-1, respectively, through a 15 × 55 μm2 cross sectional area. Referring to Figure 1.1, 
a channel with a cross section of 825 µm2 and a velocity of 1 mm s-1 with a sampling 
volume of 1 mL would require ~1600 h to complete the analysis. 
 
 
Figure 1.7 Furdui et al. presented a magnetic cell isolation strategy adapted to 
microfluidic platforms. A syringe pump was used to transport suspensions through a 





Furdui and Harrison adopted immunomagnetic techniques onto microfluidic 
platforms in order to enrich Jurkat cells (T cell leukemia) from blood, and their apparatus 
is shown in Figure 1.7.20 The model samples used Jurkat cell:erythrocyte cell ratios of 
1:10,000 with a total of 1-2 × 1010 RBCs mL-1 with a Jurkat cell frequency of 1 x 106 per 
mL. The authors removed the leukocytes from the blood prior to the microfluidic 
analysis. The magnetic beads were initially functionalized with protein A prior to 
incubating with anti-human CD43. The results of the incubation yielded antibody-
functionalized beads, where the antibodies were bound to protein A via their Fc domain. 
A magnetic zone was used to selectively isolate the magnetic particles bound to the 
target cells in the microfluidic device. Subsequent to a rinsing step, the captured cells 
were eluted after removal of the magnetism and initiation of hydrodynamic pumping. 
Following optimization, the authors were able to isolate 37% of the spiked T-cells with a 
throughput that corresponded to 3 μL min-1 from a 2 µL sample that consisted of 1,070 
Jurkat cells. 
Becker et al. extended dielectrophoresis to mixtures of MDA231 breast cancer cells 
(1 × 107 mL-1) and normal blood cells (3 × 107 mL-1).60 In their work, 30 µL aliquots of 
the suspensions were applied to a dielectrophoresis chamber. The total number of cells 
analyzed was 1.2 × 106 with a ratio of 1:3 tumor cells to normal hematopoietic cells. 
Upon 3 analyses of each sample, they were able to increase the ratio of cancer cells to 
normal cells from 1:3 to 1:1 for 10,000 cells analyzed. Analyte loss was prevalent in 
their work, in that of the cancer cells originally introduced into the device, only a small 
percentage (3.33%) of the targets were successfully isolated. It is important to note that 
typically cancer cells appear at a much lower ratios than those used in these model 
studies; ratios of 1:108 cancer cells to normal blood cells are typical. 
Mohamed et al. demonstrated the potential for size-based by developing a 
microfluidic incorporating staggered microposts with incrementally decreasing spacing 
between the posts as shown in Figure 1.8.19,22 The size-based isolation of cancer cells 
was carried out using diluted blood (1:10 blood:buffer) containing neuroblastoma cells. 
The authors demonstrated the ability to isolate neuroblastoma cells however, the 
authors did not state the capture efficiencies of the cancer cells using this device. In 
addition, the enriched cells obtained from the device had low purity with residual 
erythrocytes and leukocytes also collected within the cancer cell sample.  
 
 
Figure 1.8 Scheme of size based cell separation device presented by Mohamed et al. 
Reprinted with permission.22  
 
Chang et al. presented a device produced in glass using deep reactive ion etching 
(DRIE) that incorporated a microchannel that was 10 mm long, 500 μm wide and 40 μm 






respectively.17 The device structures were coated with E-selectin IgG chimera 
antibodies. Pure suspensions of two myeloid cell lines, HL-60 and U-937, were used to 
evaluate the ability of the microfluidic platforms to isolate cancer cells using this 
biomemetic approach. The suspensions reportedly used in this study were on the order 
of 106 cancer cells mL-1, well above a cell density typically associated with clinical 
samples harboring CTCs. The authors reported a volume throughput of 1 μL min-1, 
which would require 16.7 hrs to process 1 mL that may be necessary if the cell 
frequency is more in lines with actual clinical samples. Also, the authors indicated that 
favorable cell capture efficiencies were achieved when the device surfaces were coated 
with immobilized cells. Adams et al. demonstrated that throughput suffers when 
maximizing capture efficiency; however, it is unrealistic to process 1 mL sample sizes 
for 16.7 hrs. Chang and coworkers acheived capture efficiencies of 64% even though 
the duration of the experiment was lengthy. 
Dielectrophoresis is a phenomenon, first detailed in the early 1950s, which involves 
the translational motion of uncharged dielectric particles by non-uniform electric fields.61 
Depending on the electrode configuration and geometry used to produce the AC electric 
field, as well as the magnitude and phase variations of this field, cell-based separations 
can be affected using dielectrophoresis. Gravimetric field flow fractionation is the 
process by which particles are allowed to settle while under the influence of an axial 
flow based on their inherent interaction with gravity.62 Yang et al. combined the two 
techniques to separate cells based on the balance between the composite 
electrophoretic mobility and the gravimetric attraction of the cells to settle on the device 
floor.63 A schematic of the apparatus used in the work by Yang et al. is shown in Figure 
1.9. Results suggested that a breast cancer cell line (MDA-435) could be separated 




Figure 1.9 Field flow fractionating device was presented by Yang et al. in 1999. 
Reprinted with permission.63 
 
 
The enriched fractions of the MDA-435 cells and erythrocytes were reported to be >98% 
and >99%, respectively, from 15 fractions collected over a 30 min elution time. The final 
concentration of MDA-435 cells in the buffer processed was reported to be 5 × 106 cells 
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mL-1 at a nominal ratio of 2:3 of cancer cells:erythrocytes. The authors noted a 20 min 
distinction between elution times of the erythrocytes and cancer cells, but the model 
sample in this experiment did not harbor leukocytes. Leukocytes are significantly larger 




Figure 1.10 Diagram of Simonnet’s flow cytometry device and the proposed focused 
region of high-probability density of analyte location. Reprinted with permission.64 
 
 
Simonnet et al. attempted to port conventional high throughput, high resolution cell 
sorting using flow cytometry to a poly dimethylsiloxane microfluidic platform.64 
Conventional flow cytometry is characterized by typical flow rates of ~10 m s-1 
corresponding to sampling rates of 1,000 – 50,000 cells s-1. In order for a microfluidic to 
be considered suitable replacement for flow cytometer, it would have to approach this 
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threshold in terms of the linear velocity. A diagram of Simonnet’s device is shown in 
Figure 1.10. Briefly, flow was from left-to-right in the diagram and a cross flow was used 
to hydrodynamically focus both opposing sides of the region labeled E in Figure 1.10C. 
Using this platform the authors were able to count cells consistently at 1,200, 9,000, and 
17,000 particles s-1. As the flow rate was increased the particle number increased and 
so did the coefficient of variance (CV) in their measurements. At 1,200, 9,000, and 
17,000 particles s-1 the CVs were 3, 7.6, and 11%, respectively. Remarkably, the CV 
values for the microfluidic device rivaled those of the commercial instrument for the 
same sample set. As with the macro-scale version of the flow cytometer, to sort and 
enumerate the low abundant CTCs, specific staining protocols will need to be invoked 
as well as some sample pre-processing prior to flow assisted cell sorting.9 
 
 
Figure 1.11 Poly dimethylsiloxane microstructures with valves for used for cell isolation. 







Valves, actuators, and mechanical trapping of cells using moving parts within a 
closed microfluidic network is possible when casting elastomers, like poly-
dimethylsiloxane, against positive reliefs.25 Pressure from fluids or air are commonly 
used to open and close valves within microfluidic networks resulting in temporarily 
trapping or redirecting the flow path of cells and or fluids within the device. Irimia and 
Toner produced a device with features designed to accomplish the manipulation of 
human monocytic leukemia cells in a microfluidic device.25 In this work, 30 nL aliquots of 
human monocytic leukemia cells were use to prepare suspensions with densities 
ranging from 1 × 103 to 1 × 107 cells mL-1. The enrichment was reported to be ~1,000-
fold. Figure 1.11A shows a diagram of an actuated valve and subsequently trapped cell 
and Figure 1.11B and C show actual cells being temporarily isolated on a membrane 
and transported to a membrane, respectively. Figure 1.11D shows the effectiveness of 
the cell isolation technique by demonstrating the enrichment potential as a function of 
the input cell density.  
 Nagrath et al. isolated rare CTCs from blood samples using microfluidic devices 
that contained 78,000 microposts that were 100 µm tall and 100 µm wide in a total area 
of 970 mm2.5 At flow rates of 1 mL hr-1, 65% of CTCs were isolated from spiked PBS, 
and as the processing flow rate was increased to 3 mL hr-1 the recovery rate was 
reduced to 25% as shown in Figure 1.12. In whole blood measurements, approximately 
2.7 mL of blood was used and the CTC recovery rates were typically 61%. Enrichments 
from whole blood samples were ~50% pure after analysis and as a result, CTCs had to 
be differentiated from leukocytes, the main interferent, using fluorescently-labeled 
cytokeratin and CD45 (see Figure 1.12). Twenty healthy subjects served as controls 
and those samples evaluated negative for CTCs. 
 
Figure 1.12 Capture efficiency as a function of (A) flow rate, (B) cell line, and (C) spiked 
cells are shown along with typical micrographs of the stained cells where (D – G) show 
an event that is positive for cytokeratin and DAPI attributed to a CTC and (H – K) show 







Figure 1.13 Shevkoplyas et al. presented a micro-separation device capable of 





Shevkoplyas and coworkers presented a microfluidic that was capable of a 34-fold 
enrichment of white blood cells from samples that contained cell densities of 2,100 cells 
μL-1 to 42,300 cells μL-1 using a 10 μL whole blood sample (see Figure 1.13).65  Whole 
blood enters the device through a 70 μm supply channel. The histograms in Figure 1.13 
show that initially the cells are evenly distributed throughout the channel, but as smaller, 
more deformable erythrocytes seek the faster flow region in the center of the channel, 
the lumen of the erythrocytes collide with leukocytes forcing them to migrate toward the 
walls. The branching nature of the device provided selectivity for large cells, such as 
leukocytes, that migrate through the device at the walls, while erythrocytes migrate 
through the center of the device. Ultimately, the effluent shown in zone 8 of Figure 1.13 
has a 20-fold increase in leukocyte density from the original input. Unfortunately, the 
process was marred by significant numbers of contaminating erythrocytes, and the 
potential for handling large input volumes required for scoring the presence of low-
abundant cells was not possible due to the constricted flow after the third bifurcation in 
the analyte channel. 
Adams et al. introduced a high throughput microsampling unit capable of meticulous 
selecting very low abundant targets from complex media.24 In their work, a microfluidic 
device composed of poly(methylmethacrylate) employing many parallel high aspect 
ratio microstructures was functionalized via UV exposure providing a carboxylated 
scaffold amenable to antibody immobilization.  The immunoslection of the cells was 
affected through the use of monoclonal antibodies specific for the epithelial cell 
adhesion molecule (EpCAM), which is over-expressed in a number of 
adenomacarcinomas.  The immobilized antibodies were used to selectively isolate low 
abundant MCF-7 breast cancer cells through a cascade of antibody:antigen complex 
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formations sufficient to remove the cells from unprocessed whole blood with 97% 
recovery efficiencies. The devices were capable of high throughput operation at the 
optimal capture velocity of 2 mm s-1 such that 1 mL samples could be exhaustively 
interrogated in approximately 37 min. Further, these devices required no sample 
pretreatment by removing the red blood cell fraction via centrifugation or fluorescent 
staining of the cells due to on-chip integration using a conductance-based sensor 
capable of discriminating wild-type cells from the low abundant cancerous targets with 
near 100% detection efficiency.  
 
 
Table 1.2 Figures of Merit for CTC Isolation on Macro and Micro-Scale Platforms. 















































The analytical figures of merit for several different cell isolation strategies are 
detailed in Table 1.2 outlining the advantage and disadvantages for each of the various 
approaches for isolating CTCs from complex biological samples, such as whole blood. 
Included in this table are two representative microfluidic platforms directed toward rare 
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cell isolation. As can be seen from this data, the HTMSU example can process large 
input volume samples with high recoveries and also, due to the incorporation of the 
conductivity sensor, does not require cell staining for enumeration. 
1.6 Future of Microfluidics 
Of the various cell isolating/sorting tools developed to-date, some common 
procedural characteristics make many of them prohibitively difficult to implement; such 
as, the ability of many of the platforms to only sort the mononucleated cell fractions of 
whole blood. This criterion dictates the need for performing density gradient 
centrifugation prior to the enrichment procedure. In addition, these methods often have 
low throughput such that the probability of isolating the rare event is reduced due to the 
device capabilities of processing less than 50 µL of sample. Subsequently, the use of 
either fluorescence activated cell sorting or fluorescence microscopy is performed such 
that the target cells can be enumerated. This adds additional sample processing of the 
enriched CTCs via reactions with combinations of fluorescent markers. These 
supplemental steps necessitate sample handling and transfer, which can induce CTC 
loss or introduce contamination that can dramatically affect the assay results. This is 
especially prominent when dealing with low frequency events. To date there have been 
only two reports of self-contained systems capable of meticulously separating intact 
CTCs from peripheral blood samples allowing for the direct quantification of the CTC 
levels once enriched.5,24 
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The ability to fabricate microscale analytical devices on planar substrates with 
dimensions similar to those of biological cells has recently attracted significant attention 
in the field of bioanalysis (i.e., identification and quantification of specific cellular 
contents, such as DNA, RNA, or protein). Microfluidic devices are attractive for cellular 
analyses since many processing steps can be integrated into a single platform, 
minimizing dilution of intracellular components following lysis. The feasibility of handling 
biological cells in microfluidic devices using various physical forces has already been 
demonstrated in glass.1-5 Cell transport and sorting on microfabricated devices have 
been reported where hydrodynamic,4,6 electroosmotic,2,7 and dielectrophoretic8,9 forces 
have been used. For example, Li and Harrison2 used electroosmotic pumping in glass 
microdevices to transport cells within a network of channels. On-chip manipulations 
such as plug formation and flow switching in the channel were demonstrated. Chang et 
al.10 performed electrical characterization of microorganisms in microdevices. 
Electrophoretic movement of live and heat-inactivated bacteria confirmed the presence 
of negative charges on the surface of the cell membrane of the live microorganisms. 
The dead cells accumulated at the negative electrode suggesting alteration in the 
charge state of the cells upon heat inactivation. Cell lysis, PCR amplification, and 
electrophoretic analysis of the genetic amplicons were executed sequentially on a 
monolithic glass microchip by Waters et al.3 The entire microchip was thermally cycled 
to lyse cells and to amplify the DNA, which was carried out in a fabricated well located 
on the chip. Heo et al.11 entrapped viable E. coli cells in hydrogel micropatches within 
microfluidic systems. Small molecules, such as dyes and surfactants, were able to 
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diffuse into the gel, which caused cell lysis and released the cell contents. The cell 
debris, being sufficiently large, was retained within the gel matrix.  
The majority of research on cell transport and manipulation performed in 
microdevices has been done primarily in glass or silicon. Glass offers important features 
for cell transport because the EOF is very well characterized and has a magnitude that 
is typically greater than the electrophoretic mobility of most analytes, leading to 
migration of all materials, irrespective of charge, toward the cathode. The large 
electroosmotic flow in glass is due to the high surface charge of this material (i.e., 
deprotonated silanol groups).  
Polymers are viewed as attractive materials for microfluidic devices due to their 
flexibility in micromanufacturing structures, ability to pattern high aspect ratio 
microstructures, and the low cost of replicating daughters from masters using 
embossing or injection molding.12 Unfortunately, many polymers (e.g., 
poly(methylmethacrylate), high and low density polyethylene, polystyrene, 
polypropylene, polycarbonate) do not contain ionizable functional groups and, as such, 
produce much smaller EOFs compared to glass.13,14 In terms of cell transport, small 
EOFs can be problematic due to a lack of well-defined transport control.  
The EOF, however, can be altered by chemical modification of the polymer substrate 
leading to the introduction of new ionizable groups on the surface. Successful chemical 
modification of PMMA and PC has been reported previously in our lab.15,16 The EOF of 
amine-terminated PMMA microchannels was shown to be reversed compared to that in 
unmodified channels. Another way to modify polymers is exposure to UV light. UV 
irradiation causes photo-oxidation, resulting in a thin surface layer of oxidized 
polymer.17-20 For example, PC exposed to 254-300 nm light results in the formation of 
polymer phenyl salicylates and hydroxybenzophenones.18,19 Also, hydroxyl-containing 
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and keto-containing products have been reported.18,19 In general a wide range of 
carbonyl-containing functionalities is produced during UV-modification resulting in highly 
oxygenated surfaces even though the carbonate groups are depleted. PMMA photo-
oxidation produces alcoholic groups that are both hydrogen-bonded to ester groups, 
and/or self-associated.17 Such photo-processes are easy to perform and introduce 
additional groups on the polymer surface with fairly high quantum yields. Therefore, UV 
exposure of polymers can be viewed as a simple method to induce changes in the 
EOF.14,21,22 
The goal of the work presented herein was to characterize the electrokinetic 
transport properties of whole cells in polymeric microfluidic devices. The channels of the 
polymer microdevices were either pristine or UV-modified in order to change the 
chemistry of the walls, and consequently changing the EOF. We report on chip transport 
and monitoring of bacterial (Escherichia coli) and baker’s yeast cells (Saccharomyces 
cerevisiae). Two important analytical features will be presented; (i) control of cell 
transport (i.e., flow direction and velocity) by electroosmotic/electrokinetic forces, and (ii) 
sorting of Escherichia coli cells from Saccharomyces cerevisiae using differential 
migration in appropriately prepared material and buffer conditions.  
2.2 Materials and Methods  
2.2.1 Cells and Reagents. Baker’s yeast cells type II (Saccharomyces cerevisiae) and 
nonpathogenic Escherichia coli type B cells were obtained from Aldrich (Milwaukee, WI). 
The stock solutions of phosphate buffer saline (PBS, 100 mM pH=3.0, 7.4, and 9.0, 
Aldrich) were reagent-grade quality. Concentrations of 0.5, 1.0 and 20 mM PBS were 
prepared by dilution of the stock PBS solution with deionized (DI) water (17.9 MΩ) from 
an E-pure water purification system (Barnstead, Dubuque, IA). Cells were washed two 
times with DI water and centrifuged (1000 rpm). Next, they were placed in buffer and 
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stored in a refrigerator at 4oC until used (≤ 4 hrs). Cell suspensions for baker’s yeast 
and E. coli were 0.30 and 0.33 mg/mL, respectively, unless stated otherwise. Before 
each measurement, cells were vortexed (Vortex-2 Genie, VWR Scientific, and 
Westchester, PA) for ~5-7 min. 
 
 
Figure 2.1 A) Photograph of a polymer microdevice with 200 µL buffer reservoirs and 
interconnects attached to the inlet and outlet ports. Microdevice parameters: channel 
length = 4 cm, side channel lengths = 0.5 cm, channel width = 50 µm, and channel 
depth = 80 µm. The solid black line represents the device topology. B) Optical 
micrograph of a PMMA microdevice channel filled with E. coli and C) baker’s yeast cells 
(S. cerevisiae) in 1 mM PBS, pH=7.4. These images were obtained using a 100x 
immersible objective. The observed area under the microscope was 60 x 80 µm. The 
dotted circles in B) highlight E. coli cells contained within the device. 
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2.2.2 Microchip Fabrication. Polymer microchips were fabricated using LIGA as 
previously reported.12,23,24 The procedure involved fabricating a metal molding die, which 
consisted of raised microstructures of Ni on a stainless steel base plate. The device 
used in these studies possessed a 50 µm wide and 80 µm deep channel of 4 cm total 
length and configured in a cross with side channels of 0.5 cm in length.  
Devices were prepared in polycarbonate (PC) and poly(methylmethacrylate) 
(PMMA). PC and PMMA stock sheets of 5.0 mm thickness (Goodfellow, Berwyn, PA) 
were cut into 133 mm diameter round disks. Discs were washed with 2-propanol and 
distilled water and dried in an oven at 80°C overnight. The microchannel pattern was 
hot embossed into the polymer plates using a PHI Precision Press model number TS-
21-H-C (4A)-5 (City of Industry, CA). A vacuum chamber was installed into this press to 
remove air (pressure <0.1 bar) so complete filling of the die could take place. 
Embossing was performed at 1000 lbs pressure for 4 min at 190°C for PC and 150°C 
for PMMA. 
Before final assembly, chips were washed with soap, rinsed with DI water and 2-
propanol, and then ultrasonicated for 15 min in DI water. The channels were examined 
under a microscope to ensure they were not filled with debris. The embossed devices 
were assembled by heat annealing a coverplate made from the same material to the 
substrate. The coverplate and substrate were clamped together and placed in a 
convection oven for ~20 min at 150°C for PC and 105°C for PMMA. After successful 
heat annealing, 1 mm holes were drilled into the coverplates and the microfluidic 
reservoirs/ports were attached with epoxy resin to the inlet and outlet holes. High 
volume reservoirs (~200 µL) minimized loss of buffer due to evaporation and reduced 
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the movement of cells due to capillary or hydrodynamic forces. Figure 2.1A shows a 
photograph of a fabricated device. 
2.2.3 Surface Modification. The hot-embossed PC and PMMA microchannels and 
coverplates were modified prior to assembly by exposure to UV radiation (15 mW/cm2) 
for 30-40 min using a UV lamp (ABM, Inc., San Jose, CA). After illumination, all of the 
polymer parts were rinsed with 2-propanol and sonicated for 5-10 min in DI water. The 
devices were assembled also by heat annealing, however, at lower temperatures 
compared to the non-exposed materials (144°C for PC and 98°C for PMMA). It was 
observed that UV modification of the polymer lowered its glass transition temperature 
(Tg), thus requiring a lower annealing temperature.  
 In an effort to simplify device production a post annealing UV treatment was 
attempted, whereby the devices would undergo thermal annealing as detailed earlier 
prior to UV modification. In order to test the protocol planar PMMA substrates were UV 
modified using incrementally increasing UV exposure doses. Water contact angle 
measurements were performed on both the incident and opposing sides of the modified 
PMMA to determine water contact angles. Pristine PMMA has a water contact angle of 
85º and depending on the UV dose the water contact angle can be significantly 
decreased indicating the formation of a hydrophilic surface.25 We observed no change 
in the hydrophilicity of the opposing side of the planar PMMA indicating that the surface 
modification was limited to the incident side of the exposed PMMA (see Figure 2.2). 
2.2.4 Derivatization of UV-modified PMMA and PC. UV-exposed PMMA and PC 
surfaces were derivatized with a diamine crosslinking agent followed by covalent 
attachment of an amine-selective dye to determine the presence and identity of 
















































































Scheme 2.1 Modification protocol of PMMA and PC surfaces. The material was first 
exposed to UV radiation through a photomask. The groups formed as a result of 
exposure were derivatized with ethylene diamine in the presence of EDAC. Any 
surface-bound primary amines were subsequently reacted with FITC to produce 
fluorescence. F = fluorescein.  
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Precut pieces of 0.5-mm-thick PC (Goodfellow) and PMMA (AIN Plastics) were 
sonicated in 2 propanol for 15 min and subsequently rinsed again with 2-propanol, then 
dried with high-purity nitrogen. A 500-mesh Ni grid was placed over the PC and PMMA 
pieces, then the masked pieces of the polymer sheets were placed 1 cm from the UV 





































Figure 2.2 Plot of water contact angles of the incident and opposing sides of PMMA 
taken immediately after modification. The black triangles indicate the water contact 
angles of the opposing sides of PMMA which are equal to that of unmodified pristine 
PMMA. The blue squares show the moderate reduction in water contact angle resulting 
from the incident irradiation. Data points and error bars reflect the average of three 
measurements and the associated standard deviation from that average, respectively.  
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Upon removal from the UV source, the PC and PMMA pieces were sonicated in 
nanopure water for 5 min. The cleaned, exposed pieces were then incubated with 
agitation for 11 h in a 5 mM EDAC (1-ethyl-1-(3-dimethylaminopropyl)carbodiimide) with 
100 mM phosphate buffer (pH=7.0) containing 5 mM ethylenediamine (Aldrich). The 
resulting amine-terminated surfaces were then rinsed with Nanopure water and placed 
in a 2 mM FITC (fluorescein isothiocyanate) solution in pH 9.0, 0.1 M borate buffer for 4 
h, after which they were rinsed with borate buffer and dried in air. Examination of the 
derivatized surfaces was achieved with a Nikon Miphot-FXA microscope with a 20X 
fluorescence objective equipped with a 510 nm excitation filter and a 520 nm barrier 
filter. 
The surface morphology of pristine and UV-modified PMMA and PC surfaces was 
interrogated using atomic force microscopy (AFM), (Nanoscope III, Digital 
Instruments/Veeco Metrology Group, Santa Barbara, CA) in the non-contact (tapping) 
mode. 
2.2.5 Measurement of the Electroosmotic Flow (EOF). The EOF in assembled 
devices was measured using the method described by Zare and co-workers.26  The 
procedure involved filling the entire chip with a 20 mM buffer. After filling the chip, one 
reservoir was emptied and filled with the same type of buffer but of lower ionic strength 
(18 mM). An electric field (150 V/cm) was then applied to the reservoirs containing the 
low and high ionic strength buffers and the current was monitored continuously using a 
strip-chart recorder (Kipp and Zonen Inc., Bohemia, NY). The time needed for the 
current to reach a plateau was measured from the plot and the linear velocity calculated. 
Dividing the linear velocity by the electric field strength produced EOF values (cm2/Vs). 
The electric field was supplied by a Spellman high-voltage power supply (CZ1000R, 
Plainview, NY). The electroosmotic flow measurements were carried out through pH 
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values of 4-10 on both pristine and UV-modified PMMA and PC microchips. Three 
different buffers were used over the investigated pH range; acetate buffer (pH=4.0, 
pH=5.0, and pH=6.0); phosphate buffer (pH=7.0 and pH=8.0); and borate buffer 
(pH=9.0 and pH=10.0).  
2.2.6 Cell Transport. Observations of cell transport were performed using a Nikon 
Optiphot 2 microscope (Nikon, Melville, NY) equipped with a JAI CV 252 monochrome 
video camera capable of capturing 30 fps. The images were captured directly to the 
hard drive of a Dell Precision 500M workstation via a Pinnacle Systems DV500 video 
capture card that was interfaced to a Pinnacle Systems Bluebox (Pinnacle Systems, 
Inc., Mountain View, CA). The Bluebox served as a conduit for the video transfer to the 
computer. Adobe Premiere 6.0 (Adobe Systems, Inc., San Jose, CA) was used for data 
acquisition and subsequent data processing.   
The programmable high voltage power supply (PHV) was assembled in-house. The 
unit consisted of 4 individual power supplies (Model UR5PN, Matsusada Precision Inc., 
Santa Clara, CA) capable of delivering +5 to -5 kV, ground, and floating potentials. Each 
power supply was equipped with an independent Reed relay (Model RR1A07P06, Ross 
Engineering Corporation, Campbell, CA) that was used to toggle the polarity, ground, 
and floating states of the power supply. The power supply was computer controlled with 
a 4 channel 12 bit digital to analog board (Model CYDDA 04P, CyberResearch Inc., 
New Haven, CT) with peripheral component interface (PCI) and software written in 
Labview (National Instruments, Austin, TX). All experiments were carried out at room 
temperature. Caution! The electrophoresis uses high voltages and special care should 
be taken when handling the electrodes. 
2.2.7 Backscatter Cell Detection. The detection system used for monitoring cell 
transport via backscatter detection has been described in detail previously.27 It 
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consisted of a diode laser (LDH 680, PicoQuant, Berlin, Germany) lasing at 680 nm. 
The diode head was coupled directly to a single-mode fiber for transporting the light to 
the detector head. The collimated laser light was directed by a dichroic mirror (Omega 
Optical, Brattleboro, VT), which reflected the laser light when the mirror was positioned 
at a 45º angle of incidence. The laser light was then focused into the microdevice 
channel using a 40X, 0.65 numerical aperture (Θ= 40.5º) microscope objective (Nikon, 
Melville, NY). The scatter signal was collected by this same objective, transmitted 
through the dichroic, and focused onto a multimode fiber using an objective of the same 
power (1:1 imaging). The multimode fiber carried the resulting signal to the detector. An 
interference band-pass filter (710AF30, Omega Optical, Brattleboro, VT) and long-pass 
filter (705AELP, Omega Optical, Brattleboro, VT) were used to isolate the appropriate 
signal. The scattered signal was then focused by a 20X objective (Nikon) onto a SPAD 
(SPCM-200 single-photon avalanche diode, EG&G optoelectronics, Vaudreuiel, 
Canada). The output pulses produced from the SPAD were amplified (6954 B5 amplifier, 
Phillips Scientific, Ramsey, NJ) and fed into a counting board resident on the PC bus 
(PicoQuant SPC 430).  
2.3 Results and Discussion 
The cell types studied herein varied in size and shape. Baker’s yeast cells 
(Saccharomyces cerevisiae) are spherical eukaryotic cells with 5-10 µm diameters. 
Escherichia coli are bacteria cells with rod-like shape and dimensions of about 1-2 µm. 
These cells posses a net negative charge at physiological pH, which along with its size 
determines its electrophoretic mobility.2 This charge is a result of 
protonation/deprotonation of membrane bound materials. Thus, cell charge can be 
controlled by altering the properties of the buffer solution (i.e., pH, ionic strength, salt 
composition). It has previously been observed that cells suspended in an isotonic salt 
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solution start to move toward a positively charged electrode upon application of an 
electric field.28 The speed of the movement (i.e., electrophoretic mobility) was found to 
be proportional to the density of charges located on the cell surface.  
Figure 2.1B and 2.1C present photomicrographs of E. coli (B) and baker’s yeast 
cells (C) in a PMMA microfluidic device. Cell velocities in the present study were 
calculated by measuring the time a cell migrated a distance of 80 µm, which was the 
field of view for the objective used in these studies. The average velocity was based on 
values obtained from 5-7 different cells. 
2.3.1 Electroosmotic Flow in Polymeric Devices. The most common mechanism of 
pumping in microfluidic devices is electrokinetic, which utilizes the electroosmotic flow of 
the solution and the electrophoretic mobility of the material being transported. The linear 
velocity at which the material moves is governed by Eq. 2.1;  
νapp= (µeof + µep)E  (2.1) 
where νapp is the apparent linear velocity (cm/s) and is determined from the sum of the 
electroosmotic mobility (µeof) and the material electrophoretic mobility (µep) multiplied by 
the field strength (E). Throughout this work, mobilities reported from anode to cathode 
are positive, and those from cathode to anode are negative. 
By modifying the channel surface, we could control the magnitude and direction of 
the EOF, resulting in control of transport rate and direction. A simple way to modify 
polymers is through exposure by UV light. UV irradiation causes photo-oxidation of the 
surface and leaves the bulk material unmodified.14,17-22 While previous studies14,20-22 
utilized UV lasers (excimer) to induce these surface charge density changes during 
ablative processes, we used a broadband UV source with moderate photon densities, 
which would be expected to minimize any polymer ablation.  
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Figure 2.3 Plot of EOF vs. pH for unmodified and UV-modified PMMA and PC. The 
electroosmotic flow measurements were carried out through pH values of 4-10. Three 
different buffers were used; acetate buffer (pH=4.0, pH=5.0, and pH=6.0); phosphate 
buffer (pH=7.0 and pH=8.0); and borate buffer (pH=9.0 and pH=10.0). The low 
concentration of buffer was 18 mM and the higher concentration was 20 mM. The field 
strength used was 0.15 kV/cm. The EOFs were measured using the chips described in 
Figure 2.1. For the UV-modified chips, both the coverplates and substrates were 
exposed prior to chip assembly. 
 
The EOF values for pristine and UV-modified polymers as a function of pH are 
plotted in Figure 2.3. The EOFs for both PMMA and PC as well as for UV-modified 
PMMA and UV-modified PC were positive, indicating solution flow from anode to 
cathode and thus, negatively charged walls. For the pristine PMMA microdevice, the 
observed EOF was 1.72×10-4 at pH=4 and increased to 3.02×10-4 cm2/Vs at pH=9, 
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consistent with our previous data.15,16,29 A much larger EOF was seen for the UV-
modified PMMA devices (e.g., 1.88×10-4 at pH=4 and 4.67×10-4 cm2/Vs at pH=9). EOFs 
measured in the UV-modified PC microchannel showed higher values than in 
unmodified PC as well (e.g., 4.73×10-4 and 3.50×10-4 cm2/Vs at pH=7.0 for UV-modified 
and pristine PC, respectively). These results can be explained by the production of 
higher negative charge densities on the UV-modified material due to the presence of 
ionizable groups with lower pKa values than the terminal phenolic groups found in 
pristine PC.18,14,21,22 The first derivative of the plots of EOF vs. pH for both UV-modified 
PMMA and PC revealed an apparent surface pKa value of 4.2 for UV-modified PMMA 
and 4.3 for UV-modified PC. Based on these results, we can speculate that carboxylate 
groups are present on both the UV-modified PMMA and PC, since typical literature 
values of pKa for alkyl or aryl carboxylic acids are in the range of 4-5. 
In order to determine the identity of these charged groups on the surface of PMMA 
and PC exposed to low intensity broadband UV illumination, both PC and PMMA sheets 
were subjected to UV radiation through a TEM grid and the resulting material reacted 
with a diamine in the presence of EDAC, which selectively labels carboxylate groups to 
create an amine-terminated scaffold that could be subsequently reacted with FITC.  
Following derivatization, the material was imaged using a fluorescence microscope. The 
resulting images (brightfield and fluorescent) are shown in Figure 2.4. From these 
images, it can clearly be seen that only those areas exposed to the UV radiation 
through the TEM grid produced substantial amounts of fluorescence. Since EDAC 
coupling of the diamine to the surface is a good indicator of the presence of carboxylate 
groups, it can assumed that UV exposure induced a photo-oxidation reaction, similar to 
that observed by Locascio and co-workers for laser ablated polymer surfaces.14 A 
brightfield image of the PC surface, which can provide information on surface 
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morphology, showed no distinct features following UV exposure, indicative of no 
significant amounts of surface ablation induced by this dose.  
 
 
Figure 2.4  Brightfield A, C) and fluorescence B, D) images of PC A, B) and PMMA C, 
D) surfaces exposed to broadband UV radiation through a TEM grid and subsequently 
reacted with ethylene diamine in the presence of EDAC. Prior to fluorescence imaging, 
the functional amine scaffold was reacted with FITC. The fluorescence images were 
acquired using 510 nm excitation with the emission monitored at ~520 nm. The PMMA 
and PC sheets were exposed to broadband UV radiation (15 mW/cm2) for 35 min. 
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However, in the case of PMMA, evidence of slight morphological changes were 
apparent following UV exposure as indicated by the presence of features defined by the 
TEM grid. However, in the case of PMMA, evidence of slight morphological changes 
were apparent following UV exposure as indicated by the presence of features defined 
by the TEM grid. AFM images of this surface (see Figure 2.5) indicated a trough depth 
of approximately 75 nm. 
2.3.2 Cell Transport in Pristine PMMA and PC. Figures 2.6A and 2.6B shows the 
linear velocity dependence upon the applied field for baker’s yeast cells in PC (A) and 
PMMA (B) with 0.5, 1.0, and 20 mM PBS at pH=7.4. The negatively charged cells would 
be expected to migrate in the direction of the anode due to electrophoretic effects, 
however, at each buffer concentration in both PC and PMMA baker’s yeast cells 
migrated toward the cathode (same direction as EOF). 
Clearly, the mobility of these cells is smaller than the EOF resulting in net flow toward 
the cathode. It was also observed that the flow velocity of baker’s yeast cells in these 
polymer devices decreased with increasing buffer concentration. It is well known that 
increasing the concentration of the electrolyte will decrease the EOF due to 
compression of the double layer.30 Because the apparent mobility is dependent on the 
EOF, decreases in the EOF result in lower mobilities when the apparent mobility is in 
the same direction as the EOF, as observed here.  
Plots of linear velocity versus electric field were used to extract the apparent 
mobilities (µapp) for both types of cells. Table 1 shows a summary of the estimated µapp 
for both Escherichia coli and baker’s yeast (Saccharomyces cerevisiae) for pristine 
polymers in PBS at pH=7.4. The µapp of  the yeast cells in PC were +2.84x10-4, 
+1.87x10-4, and +0.70x10-4 cm2/Vs in 0.5, 1.0, and 20 mM PBS, respectively, where the 




Figure 2.5 AFM images of PMMA following exposure to broadband UV radiation. See 
Materials and Methods section for experimental details. 
 
The µapp of these cells in PMMA were lower compared to PC due to the lower EOF in 
PMMA but still migrated toward the cathode.12,16,29 Figures 2.6C and 2.6D show the flow 
velocity dependence on the applied potential for E. coli cells in PC (C) in 0.5, 1.0, and 
20 mM PBS and PMMA (D) in 0.5 and 1.0 mM PBS at pH=7.4. E. coli cells show 
opposite behavior to that observed for baker’s yeast in both polymeric materials with 0.5 





Figure 2.6 Flow velocity versus applied field strength for baker’s yeast cells on PC (A) 
and PMMA (B) microdevices, and E. coli cells on PC (C) and PMMA (D) microdevices. 
Channel dimensions the same as stated in Figure 2.1. All velocities were obtained in 
PBS buffer (pH = 7.4) at concentrations of 0.5, 1.0, and 20.0 mM. 
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At these conditions, the electrophoretic mobility of E. coli cells was greater than the 
EOF and resulted in migration toward the anode. Interestingly, in 20 mM PBS the 
direction of cell movement in PC (as well as in UV-modified PC and UV-modified 
PMMA) was reversed, and the cells migrated in the direction of the cathode. In pristine 
PMMA at 20 mM PBS, mixed mobilities were observed; some cells moved toward the 
cathode and some in the direction of the anode. Clearly, there is some additional factor 
that governs or influences the transport of E. coli in 20 mM PBS. One would expect that 
since the EOF would be reduced at higher ionic strength compared to 0.5 and 1.0 mM 
PBS the cell apparent mobility would decrease if its µapp was positive.  
 
Table 2.1 Values of apparent electrophoretic mobility (µapp) for E. coli and baker’s yeast 
(S. cerevisiae) cells in pristine and UV-modified polymers with phosphate buffer saline 
(PBS) pH=7.4.  
 
Cell type PBS  pH=7.4 





x 104 cm2 V-1 s-1 
S. 
cerevisiae   
0.5 mM  (+)  2.57±0.11 (+) 2.84±0.12 (+) 3.64±0.05 (+) 4.83±0.80 
1.0 mM  (+) 1.62±0.06 (+) 1.87±0.10 (+) 1.96±0.16 (+)  2.53±0.21 
20 mM  (+) 0.66±0.07 (+) 0.70±0.02 (+) 0.71±0.02 (+)  0.92±0.04 
E. Coli      
0.5 mM  (-) 0.84±0.04 (-)   0.53±0.05 (-) 0.80±0.06 (-) 0.56 ±0.10  
1 mM  (-) 1.04±0.01 (-)   0.66±0.05 (-) 0.88±0.04 (-) 0.76±0.10
20 mM  mixed flow directions (+) 0.16±0.01 (+) 0.14±0.04 
(+) 
0.28±0.01 




The electrophoretic behavior (i.e., electrophoretic mobility) of cells is mainly controlled 
by pH and ionic strength of the medium. Both the degree of dissociation of the 
functional groups on the cell surface and the thickness of the double layer surrounding a 
cell are determined by the medium pH and ionic strength, respectively, which can 
change the electrophoretic mobility.31 For a rigid colloidal particle with a constant 
surface potential, Smoluchowski theory predicts that electrophoretic mobility of particles 
will decrease proportionally to the square root of the increase in ionic strength.32 This 
model, however, may not be applicable in the present case since biological cells are 
considered to be non-rigid.33-38 Ohshima and co-workers pointed out that the 
electrokinetic behavior of microbes with extracellular polymer layers (i.e., “soft” 
particles) will be different from that of rigid particles.33,35 Levine et. al. found that the 
electrophoretic mobility of red blood cells is smaller than that calculated according to the 
Smoluchowski equation.34 Recently, the electrophoretic mobility of a biological cell was 
studied by Hsu et al.36 The authors investigated the effect of pH and ionic strength of 
the medium on the electrophoretic mobility of the cell. They concluded that for “soft” 
particles, the electrophoretic mobility decreases with an increase in ionic strength due to 
a thinner double layer surrounding the cell and the stronger shielding effect of counter-
ions.36  
Results for E. coli cells suggest that at low ionic strength (i.e., 0.5 and 1.0 mM PBS) 
the electrophoretic mobility was greater than the EOF and resulted in migration toward 
the anode. At high ionic strength cell electrophoretic mobility decreased faster than the 
EOF in PC resulting in cell migration toward the cathode. In pristine PMMA with 20 mM 
PBS, the EOF is suppressed by high buffer concentrations causing some cells to 
migrate with the EOF and others against it due to differences in individual cell’s 
electrophoretic mobility giving rise to mixed mobility directions.  
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2.3.3 Cell Transport in UV-Modified PMMA and PC. In both UV-modified polymers, 
baker’s yeast cells moved toward the cathode. The µapp of baker’s yeast cells decreased 
with increasing buffer concentration consistent with a lower EOF at higher ionic strength. 
The apparent mobility of baker’s yeast in UV-modified PC was +4.83x10-4, +2.53x10-4, 
and +0.92 x10-4 cm2/Vs in 0.5, 1.0, and 20 mM PBS, respectively. These µapp are higher 
than those obtained in unmodified PC, consistent with a larger EOF for mobilities that 
are electroosmotically dominated. The µapp of baker’s yeast cells in UV-modified PMMA 
was higher than those in pristine PMMA. 
The µapp for E. coli cells in UV-modified PC was found to be -0.56x10-4, -0.76x10-4, 
and +0.28 x10-4 cm2/Vs in 0.5, 1.0, and 20 mM PBS, respectively. As can be seen, the 
sign of µapp indicates cell travel toward the anode, opposite to the EOF, except with the 
highest ionic strength buffer where the cells migrated toward the cathode, similar to 
what was observed in unmodified PC. In the case of UV-modified PMMA, the µapp of 
these cells was -0.80x10-4, -0.88x10-4, and +0.14x10-4 cm2/Vs in 0.5, 1.0, and 20 mM 
PBS, respectively. The µapp of E. coli migrating in UV-modified PMMA was lower than in 
unmodified PMMA. For example, in 1 mM PBS at pH=7.4 µapp was -0.88x10-4and -1.04 
x10-4 cm2/Vs in UV-PMMA and PMMA microchannels, respectively. 
It was found that the EOF in both pristine and UV-modified polymeric devices 
showed an increase in magnitude at higher pH values (see Figure 2.3). We therefore 
tested the behavior of the cell mobility in microfluidic channels of different buffer pHs in 
1 mM PBS. It was observed that the µapp of baker’s yeast increased with increasing pH. 
For example, in PC with 1 mM PBS µapp were +1.05(±0.10)x10-4, +2.25(±0.20)x10-4, and 
+2.40(±0.40)x10-4 cm2/Vs; and for UV-PC they were +1.15(±0.20)x10-4, +2.65(±0.40) 
x10-4, and +2.80(±0.4)x10-4 cm2/Vs, at pH 3, 7.4, and 9.5, respectively. The µapp 
increased for both pristine and UV-modified PC with increases in pH, consistent with 
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larger EOF values at higher pHs. However, the extent of the increase was more 
significant for UV-modified PC due to its larger increase in EOF at higher pH values 
compared to pristine PC. Similar trends were also observed for PMMA and UV-PMMA.  
The EOF in glass has a magnitude that is typically greater than the electrophoretic 
mobility of most analytes or cells. Thus all materials, irrespective of charge, tend to 
migrate toward the cathode. The µapp measured in 200 mM PBS (pH=7.4) in glass by Li 
et al.2 for baker’s yeast cells was +3.50(±0.57)x10-4 and +2.00(±0.36)x10-4 cm2/Vs for E. 
coli. In glass, both types of cells migrated with the EOF. For the polymers investigated 
herein, only baker’s yeast cells (regardless of polymer or the buffer ionic strength) 
migrated with the EOF. The largest µapp of baker’s yeast cells in polymer microdevices 
was observed for UV-modified PC in 0.5 mM PBS (see Table 1). We have found that 
the largest µapp for E. coli cells was observed in PMMA in 1 mM PBS (see Table 1). The 
largest µapp for cells moving with the EOF was observed in UV-modified PC in 20 mM 
PBS (+0.28 x10-4 cm2/Vs). This value is an order of magnitude lower than that observed 
in glass.2  
Chip-to-chip reproducibility of the measured EOFs and cell flow velocities varied 
slightly, however, the direction of the cell transport was reproducible from chip-to-chip. 
For example, in 3 different PMMA microdevices, RSD values for the velocities were 
approximately 10-12% for both types of cells. For a single microdevice, the RSDs for 
flow velocities were usually 5-10% with up to 20% at high applied fields. It was found 
generally that the RSD for E. coli cells were higher than those for baker’s yeast. Similar 
values for the relative standard deviations have been observed for glass chips 
(RSD=10-18%).2  
2.3.4 Cell Adsorption. Cell adhesion and adsorption in a microfluidic device can lead to 
flow problems mainly due to clogging of the device. Bare silicon and glass surfaces are 
 73
particularly prone to cell adhesion, promoting biofouling under both static and flow 
conditions.28 Such problems are especially pronounced when high cell counts are 
used.2 The hydrophilic nature of the glass surface makes them unsuitable in many 
cases for cell assays without modification. Cell adhesion has been shown to be reduced 
by modification of the glass channel walls with trichlorohexadecylsilane,2 or 
poly(dimethylacrylamide).39,40 Covalent and non-covalent modification of the channel 
surfaces has been performed with silane coupling agents, such as 
octadecyltrimethoxysilane (ODTMS),28,39 N-(triethoxysilylpropyl)-O-polyethylene oxide 
urethane (TESP),28 and (tridecafluoro-1,1,2,2-tetrahydrooctyl)-1-dimethylchlorosilane 
(F13) to minimize cell adsorption.39  The TESP coating was effective at inhibiting glial 
cell biofouling, allowing the device to operate for several minutes without failure. The 
ODTMS coatings, on the other hand, promoted glial cell adhesion leading to restricted 
flow within a few minutes.28 In studies with E. coli cells, ODTMS and F13 were found to 
be too hydrophobic for use with aqueous solutions.39  
Unmodified PMMA and PC possess more hydrophobic surfaces compared to 
glass.16 UV-radiation of these polymers modifies the surface making them more 
hydrophilic and potentially more susceptible to cell adhesion.2,39  Indeed, we noticed 
minimal cell adhesion/adsorption to the channel wall, channel bottom or coverplate for 
the unmodified materials. Even after 1 hr of operation, the channels in unmodified 
polymeric microdevices remained unclogged and functional. Although the clogging of 
the channels in UV-modified polymers was also not experienced after 1 hr of operation, 
it was observed that more yeast cells adhered to these channel surfaces. It was noticed 
during microdevice operation that some of the immobilized/adsorbed cells could be 
removed by applying higher fields. This was partially caused by an increase in the 
number of collisions between flowing and stagnant cells as well as stronger fields that 
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were able to “lift” cells from the polymer surface, suggesting that the adhesion forces of 
the cell to the polymer surface (UV-modified) were not strong enough to withstand drag 
forces produced by the EOF. 
2.3.5 Cell Sorting. Figures 2.7A and 2.7B show light scattering signals generated for 
two separate suspensions of unlabeled baker’s yeast cells (A) and E. coli (B) in 1 mM 
PBS (pH=7.4) using a PMMA microchip. Cells were driven separately using 
electrophoretic/electroosmotic forces in the device with a field strength of 0.2 kV/cm. E. 
coli cells migrated toward the anode and baker’s yeast cells toward the cathode. Each 
scatter signal most likely represents passing of a single cell through the laser beam. 
Histograms built for each run are presented in Figure 2.7C. It is evident that the 
scattering signal for baker’s yeast cells is larger than that for E. coli. The average signal 
was 1,350±432 and 268±86 cps for baker’s yeast and E. coli, respectively. The 
observed difference in the magnitude of the scatter signal is mainly due to differences in 
size of these two types of cells, but may also reflect shape or surface roughness 
differences.6,7,39,41-43  
 The observed differential cell migration behaviors in polymeric devices suggested 
the possibility of presorting these two types of cells electrophoretically. Nano-particles 
and biological cells have been shown to be sorted on the basis of their dielectric 
properties.44 Sorting was based on the fact that when particles are placed in an AC 
electric field, polarized particles experience a variable translational force, which 
depends on the applied frequency. Since the polarization is frequency dependent, the 
net force is also dependent on frequency. Thus, by manipulation of the medium 









































Figure 2.7  Light scattering signals generated for a suspension of unlabeled baker’s 
yeast cells (A) and E. coli cells (B) in 1 mM PBS, pH=7.4 in a PMMA microchip. The two 
types of cells were run separately. Also shown in (C) are histograms of frequency 
versus scattering signal intensity obtained from baker’s yeast and E. coli cells 
constructed from the data in (A) and (B). Scattering data were generated with the 680 
nm laser at a power of 0.25 mW with a sampling time of 0.5 s. The cells were 
electrophoretically/electroosmotically driven at 0.2 kV/cm using the chip described in 
Figure 2.1. 
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Figure 2.8 Light scattering signals generated for a suspension of an unlabeled mixture 
of baker’s yeast and E. coli cells in PBS (pH=7.4) in a PMMA microchip. A) The anodic 
reservoir was filled with baker’s yeast and E. coli cell suspensions prepared in 20 mM 
PBS, B) the anodic reservoir was filled with baker’s yeast and E. coli cell suspensions 
prepared in 1 mM PBS, and C) the cathodic reservoir was filled with both cell types in 1 
mM PBS (pH=7.4). See Figure 2.7 for experimental details. 
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We present a simple method of sorting two types of cells based solely on their 
electrophoretic mobilities. By judicious choice of; (i) the buffer concentration in which the 
cell suspension is prepared and; (ii) the polymer material and preparation, we can 
selectively introduce a certain cell type into a microfluidic device from a mixed 
population of cells. Figures 2.8A-C show scatter data collected for a mixture of 
electrically driven baker’s yeast and E. coli cells in an unmodified PMMA microchannel. 
In Figure 2.8A, the anodic reservoir was filled with both baker’s yeast and E. coli cells 
suspended in 20 mM PBS. At these conditions, the scattering signal was collected for 
both baker’s yeast and E. coli cells, since both types of cells enter the microchannel. 
When the anodic reservoir was filled with the mixed cell population (baker’s yeast and E. 
coli) and suspended in 1 mM PBS (pH=7.4), only high intensity signals were observed 
(Figure 2.8B). The observed scattering signal ranged from 1,500 to 4,000 cps, 
suggesting that the scatter signal was produced predominately from baker’s yeast cells 
(see Figure 2.7C). As expected, at these conditions we were able to presort E. coli cells 
from baker’s yeast cells based on their differential mobilities. Figure 2.8C shows data 
obtained in a similar experiment as in Figure 2.8B with the exception that the cathodic 
reservoir was filled with the mixed population of cells in 1 mM PBS. The scatter signal 
with low intensity peaks indicated that only E. coli cells entered the microdevice (see 
Figure 2.7C). 
2.4 Conclusions  
The use of plastics can increase the utility and diversity of devices due to differences 
in their surface chemistry and the fact that simple modification chemistries can be 
imposed on the material to affect changes in its EOF properties. Electrokinetic transport 
of Escherichia coli and Saccharomyces cerevisiae (baker’s yeast) cells was evaluated 
in microdevices fabricated in pristine and UV-modified PMMA and PC. The cell 
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velocities ranged between a few µm/s to several mm/s. For example, the largest flow 
velocity for baker’s yeast cells in these microdevices was observed for UV-modified PC 
with 0.5 mM PBS, and the lowest was measured in PMMA with 20 mM PBS. Baker’s 
yeast cells migrated with the EOF because their electrophoretic mobility was smaller 
than the EOF. The largest flow velocity for E. coli cells was observed in PMMA with 1 
mM PBS and the lowest in UV-modified PC with 0.5 mM PBS. E. coli cells migrated 
toward the cathode only when the cell suspension was prepared in 20 mM PBS. Our 
results demonstrated the feasibility of manipulating the electroosmotic flow by changing 
the ionic strength of the buffer and/or modifying the polymer material through UV 
exposure, which allowed cell sorting electrokinetically. Therefore, selective introduction 
of only one type of cell into a microdevice device from a mixed population could be 
performed.  
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Chapter 3 Highly Efficient Circulating Tumor Cell Isolation from Whole Blood and 




It is generally accepted that most cancer-related mortalities result from metastatic 
disease.1 While the process of metastasis is not well understood, a number of chemical, 
physical and molecular events occur that ultimately result in the dissemination and 
deposition of tumor cells into targeted organs using the circulatory system and/or bone 
marrow as the carrier(s). This “seed and soil” process was proposed as early as 1889 
by Paget2 and was later modified with the caveat that shed tumor cells consist of a 
heterogeneous population with sub-populations possessing different metastatic 
potentials.3 The fundamental entities primarily responsible for spawning metastatic 
disease are circulating tumor cells (CTCs), which can be produced during early stages 
of tumorigenesis.4 Elucidating the quantity of CTCs in peripheral blood or bone marrow 
can serve as an indicator for the clinical management of several cancer-related 
diseases by providing information on the success/failure of therapeutic intervention and 
disease stage forecasting.5,6 
The isolation and enumeration of exfoliated CTCs in peripheral blood or bone 
marrow for a variety of cancer-related diseases has already been reported, such as 
breast,7-9 colorectal,10 prostate,11 renal,12 bladder,13 and non-small cell lung14 cancers.  
As an example of the clinical utility of CTC information, Cristofanilli et al. recently 
reported a study of 177 breast cancer patients using the amount of CTCs in peripheral 
blood as an indicator of survival.7 Patients with ≥5 CTCs per 7.5 mL of whole blood 
possessed a median progression-free survival of 2.7 months versus 7.0 months for 
those patients containing <5 CTCs in 7.5 mL of their peripheral blood. 
*Reprinted with permission from JACS.    83 
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The major issue with securing viable clinical information via quantification of CTC 
levels is the extremely low abundance or rare-event nature of these cells amongst a 
high number of spectator cells in peripheral blood.6,15-18 For example, it is clinically 
useful to quantitatively enumerate 0-10 CTCs in whole blood composed of >109 
erythrocytes and >106 leukocytes per mL.7  
For sampling rare events in a large population, three important metrics must be 
assessed: (1) throughput, the number of cell identification or sorting steps per unit time; 
(2) recovery, an indicator of the fraction of target cells collected from the input sample; 
and (3) purity, which depends on the number of “interfering” cells excluded from the 
analysis.19  In addition to these three metrics, highly efficient quantification of the 
number of enriched cells must be provided as well.    
The approaches used to date to enrich CTCs from clinical samples have either 
provided lower-than-desired recoveries with high purity, relatively poor purity but with 
high recoveries, or in other cases, highly specialized sample processing and handling 
whose success is laboratory dependent.20-25  For example, immunomagnetic 
approaches for CTC enrichment using ferromagnetic micrometer-sized particles coated 
with molecular recognition elements specific for antigenic-bearing target cells can 
interrogate diluted blood samples typically yield modest recoveries (~70%) but 
extremely favorable purity.22 In the case of size-based separations employing nuclear 
tracked membranes, polycarbonate membranes with varying pore sizes (8 – 14 µm) can 
filter large volumes (9.0 – 18 mL) of blood and recover nearly 85% of the CTCs, but 
significant numbers of leukocytes are also retained (i.e., low purity) potentially 
complicating the enumeration process.26  Investigations utilizing reverse-transcription 
PCR, in which mRNAs are used as surrogates to report CTC levels, have the ability to 
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detect one CTC in an excess of 106 mononucleated cells.27  However, these assays are 
prone to high inter-laboratory variability and require extensive sample handling and 
manipulation.   
Most of the CTC isolation/sorting tools currently in use possess some common 
procedural characteristics that make them prohibitively difficult to implement, such as 
the ability to sort only the mononucleated fraction of whole blood requiring density 
gradient centrifugation prior to enrichment and the use of either flow cytometry or 
fluorescence microscopy following cell staining to enumerate the number of enriched 
CTCs. These additional steps require sample handling and transfer, which can induce 
cell loss or contamination that can dramatically affect the assay result, especially when 
dealing with low numbers of targets.  
Microfluidics provides a venue for producing integrated systems that can process 
clinical samples in closed architectures to minimize sample contamination and loss. 
However, high throughput sampling of relatively large volumes (>1 mL) has not been a 
mainstay for microfluidics due to the macro-to-micro dilemma resulting from the small 
dimensional features associated with these devices. For example, exhaustively 
sampling a 1.0 mL volume input using a microchannel of 30 µm × 30 µm at a linear 
velocity of 1.0 mm s-1 would require 309 h (12.9 days). This sampling bottleneck was 
recently addressed by studies with a glass-based microfluidic fabricated using deep 
reactive ion etching.28 The high-surface area immunological capture bed consisted of 
microposts (100 µm diameter x 100 µm tall) arranged in an equilateral triangular format; 
the device was capable of capturing ~60% of CTCs from untreated whole blood with 
enumeration achieved by cell staining and microscopic visualization. 
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Herein we report our efforts aimed toward the development of a self-contained 
system capable of meticulously separating intact CTCs from peripheral blood and 
directly quantifying the CTC level upon isolation and enrichment.  As a result of careful 
fluidic design rules and system integration methods, we have successfully employed a 
microfluidic system capable of exhaustively and rapidly interrogating >1.0 mL of 
unprocessed whole blood possibly harboring low-abundant CTCs. At the heart of the 
system were carefully engineered, exceedingly efficient high-aspect ratio capture beds 
decorated with mABs specific for antigenic integral membrane proteins expressed in 
CTCs of epithelial origin and a label-free, highly specific single-cell conductivity sensor. 
The device operational characteristics were achieved by tailoring the dominant CTC 
capture dynamics, specific device architecture and suspension linear velocity in a high 
throughput microsampling unit (HTMSU) containing high-aspect ratio microstructures 
replicated in a polymeric substrate. Direct single-cell counting of the captured cells was 
made possible by their release as a result of enzymatic digestion of cell-
antigen/antibody-surface complexes. Quantitative assessment of CTC numbers was 
accomplished using an integrated conductivity sensor capable of specifically detecting 
CTCs via their electrical signatures without requiring cell staining or microscopic 
visualization. 
3.2 Material and Methods 
3.2.1 HTMSU Fabrication. Figure 3.1 shows a schematic of the HTMSU and several 
micrographs of this polymer-based device. The device consisted of a series of 51 high-
aspect ratio channels that were either linear or sinusoidally configured and shared a set 





















Figure 3.1 Schematics of the HTMSU showing: (A) A scaled AutoCAD diagram of the 
sinusoidally-shaped capture channels (mould insert feature height: red is 150 μm, green 
is 80 μm, and orange transitions from 80 to 150 μm over a 2.5 mm length) with 
brightfield optical micrographs of; (B) the integrated conductivity sensor consisting of 
cylindrical Pt electrodes that were 76 µm in diameter with a 50 µm gap; (C) single port 
exit where the HTMSU tapers from 100 µm wide to 50 µm while the depth tapers from 
150 µm to 80 µm over a 2.5 mm region that ends 2.5 mm from the Pt electrodes; (D) 
micrograph taken at 5x magnification showing the sinusoidal cell capture channels; and 
(E) 3D projection of the topology of the HTMSU obtained at 2.5 µm resolution using 





See the Chapter 4 for details on the fabrication of the mold master and the micro-
replication. The substrate selected for the HTMSU was PMMA due to its high fidelity of 
forming structures with high-aspect ratios via micro-replication, minimal non-specific 
adsorption of whole blood components to its surface and its ability to generate 
functional surface-scaffolds through UV irradiation for the attachment of a variety of 
biological moieties.29 The HTMSU was manufactured via micro-replication from a metal 
master. Microstructures were milled onto the surface of a brass plate with a high-
precision micromilling machine (KERN MMP 2522, KERN Micro- und Feinwerktechnik 
GmbH & Co.KG; Germany) following our previously published procedures.30  The 
micromilling machine was fitted with a laser measuring system (LaserControl NT, Blum-
Novotest GmbH, Germany) for automatic determination of tool length and radius, and 
an optical microscope (Zoom 6000, Navitar, Inc. Rochester, NY) for monitoring the 
milling process. Micromilling was carried out at 40,000 rpm. Feed rates were dependent 
on the size of the milling tool and were typically in the range of 200 mm/min for a 500 
µm milling bit, 100 – 150 mm/min for the 200 µm bit, 50 – 75 mm/min for the 100 µm bit 
and 10-20 mm/min for a 50 µm bit. A typical milling cycle consisted of a pre-cut of the 
entire surface with a 500 µm milling bit to ensure parallelism between both faces of the 
brass plate and uniform height of the final milled microstructures over the entire pattern, 
a rough milling of the microstructures using either a 500 or 200 µm milling bit, and a 
finishing cut with a smaller diameter milling bit. In the final step of mold master 
fabrication, burrs were removed by mechanical polishing. Polishing was performed by 
hand on a 3 µm grain-size polishing paper (Fibrmet Discs - PSA, Buehler, Lake Bluff, IL) 
followed by polishing on a polypropylene cloth (Engis, Wheeling, IL) with a 1 µm 
diamond suspension (Metadi Diamond Suspension, Buehler).   
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Three identical HTMSUs were patterned onto the master enabling production of the 
units in triplicate during each hot embossing step. In order to accommodate the Pt 
electrodes used for the conductivity sensor and the inlet/outlet capillaries, the HTMSU 
was designed with multilevel features.30 The depth of the HTMSU detection zone was 
tapered to 80 µm from the 150 µm used in the cell selection beds and throughout the 
inlet region. The detection channel width was tapered from 100 µm to 50 µm over a 2.5 
mm region beginning at the converged outlet and terminating 2.5 mm from the 
conductivity electrodes scaled for specific detection of CTCs. In the cell selection bed, 
channel widths (35 μm) that closely matched the average target cell diameter were used 
to increase the probability of cell-immobilized antibody encounters. To reduce the 
pressure drops when the device was operated at high volumetric flow rates, the HTMSU 
was designed with deep (150 μm), high-aspect ratio channels. 
Prior to embossing and assembly, PMMA substrates and cover plates were cleaned 
with reagent grade isopropyl alcohol, IPA (Sigma-Aldrich, St. Louis, MO), rinsed with 18 
MΩ nanopure H2O obtained from a water purification system (D8991, 
Barnstead/Thermolyne, Dubuque, IA), sonicated for 30 min, rinsed with IPA again and 
air dried. Hot embossing was performed with a Jenoptik Microtechnik HEX02 (Jena, 
Germany). For embossing PMMA, the substrate was heated to 140°C and a pressure of 
20 kN was applied for 630 s. After the HTMSUs were hot embossed, they were cooled 
to room temperature and cleaned with IPA.  
Regio-specific ultraviolet (UV) modification of the PMMA substrate and cover plate 
was performed through an aluminum photomask to facilitate the formation of the 
carboxylated scaffold for directed antibody tethering exclusively within the cell selection 
beds of the HTMSU. Before final assembly via thermal fusion bonding, the PMMA cover 
plate and substrate were locally irradiated at 254 nm with 15 mW cm-2 fluence for 10 
min using a UV exposure station (ABM, Inc., San Jose, CA). Additionally, into the 
inlet/outlet ports of the device were inserted 237 μm OD and 150 μm ID polyimide-
coated fused silica capillaries and the Pt electrodes fabricated with the required gap 
(see Materials and Methods). After thermally annealing the cover plate to the substrate, 














Scheme 3.1 Directed antibody tethering through EDC/NHS coupling. A UV-modified 
PMMA surface is exposed to a solution containing both EDC and NHS which forms a 
stable succinimidyl ester that is subsequently reacted with an amine containing antibody 
ultimately forming a covalent amide bond. 
 
Following UV modification of PMMA, the physicochemical properties of the surface were 
effectively altered resulting in a moderate reduction of the glass transition temperature 
(Tg) at the cover plate-substrate interface. The resulting Tg allowed for efficient thermal 
fusion bonding at 101°C rather than the 106°C Tg of pristine PMMA31,32, which could 
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reduce potential thermal deformation of the high-aspect ratio microfeatures. Thermal 
fusion bonding was carried out in a gas chromatographic (GC) oven (Varian 3400, Palo 
Alto, CA) using the PMMA cover plate and the open-faced, hot embossed PMMA 
substrate. The substrate and cover plate were aligned and clamped together between 
two borosilicate glass plates and the assembly placed into the temperature 
programmable oven of the GC, where the temperature was increased from 50°C to 
101°C at a rate of 20°C/min. The temperature was held at 101°C for 15 min. 
3.2.2 Antibody Immobilization. Antibody immobilization was performed using a two 
step process. Initially, the UV-modified HTMSU device, following thermal assembly, was 
loaded with a solution containing 4.0 mg/mL of 1-ethyl-3-[3-dimethylaminopropyl] 
carbodiimide hydrochloride (EDC), 6.0 mg/mL of N-hydroxysuccinimide (NHS) in 150 
mM 2-(4-morpholino)-ethane sulfonic acid at pH = 6 (MES, Fisher Biotech, Fair Lawn, 
NJ) and buffered saline (Sigma-Aldrich, St. Louis, MO) for 1.0 hr to form the 
succinimidyl ester intermediate. The EDC/NHS solution was then hydrodynamically 
replaced with a 1.0 mg/mL monoclonal anti-EpCAM antibody (R&D Systems Inc., 
Minneapolis, MN) solution contained in 150 mM PBS at pH = 7.4 (Sigma-Aldrich, St 
Louis, MO) and allowed to react for 4 h after which the device was rinsed with a solution 
of PBS (pH = 7.4) to remove any non-specifically bound anti-EpCAM antibodies.For a 
complete description of this procedure, see the Appendix. 
3.2.3 Apparatus. A PHD2000 syringe pump (Harvard Apparatus, Holliston, MA) was 
used to hydrodynamically process samples using the HTMSU. In order to interface the 
HTMSU to the pump, a luer lock syringe (Hamilton, Reno, NV) was fitted with a luer-to-
capillary adapter (InnovaQuartz, Phoenix, AZ). The syringe pump was programmed to 
generate the appropriate volume flow rate to evaluate CTC cell capture efficiency and 
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post-capture cell retention. The linear velocities were calculated from the cross-
sectional area of the respective HTMSU capture channels and the programmed volume 
flow rate. The flow rates were validated by tracking, via optical microscopy, suspended 
cells over a fixed 80 µm region.  
During evaluative experiments, the HTMSU was fixed to a programmable motorized 
stage of an Axiovert 200M (Carl Zeiss, Thornwood, NY) microscope, which could 
monitor the transport of cells in the HTMSU using either fluorescence or brightfield 
imaging. Videos of cell transport were captured at 30 frames per second (fps) using a 
monochrome CCD (JAI CV252, San Jose, CA). For fluorescence, excitation was 
accomplished using a Xe arc lamp and dye-specific filter sets appropriate for the 
fluorescent dye used for labeling the MCF-7 cells (Carl Zeiss, Thornwood, NY). Each 
filter cube contained a dichroic mirror, emission filter, and excitation filter.   
3.2.4 Integrated Conductivity Sensor. The conductivity electrodes consisted of Pt 
wires (~76 µm) placed into guide channels that were embossed into the fluidic network 
and positioned orthogonal to the fluidic output channel (see Figure 3.1). A Pt wire was 
inserted into these guide channels prior to thermal assembly of the cover plate to the 
substrate. Once the wire was positioned, the substrate/wire assembly was placed 
between glass plates and clamped together and finally, heated to slightly higher than 
the glass transition temperature of PMMA, which embedded the wire into the guide 
channels and spanned the entire depth of the output channel. To break through the wire 
to form the electrode pair, a high precision micromilling machine (KERN MMP 2522, 
KERN Micro- und Feinwerktechnik GmbH & Co.KG; Germany) with a 50 μm bit was 
used (see Figure 3.1B). Following machining of the Pt wire and UV activation, the cover 
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plate was aligned to the embossed substrate via alignment marks and clamped together 
between two glass plates and subjected to thermal fusion bonding.    
The conductivity sensor was assembled in-house (for details see Appendix). 
Conductivity measurements were conducted in TRIS-glycine buffer containing 0.25% 
(w/w) trypsin, 0.18 mM TRIS, 47 mM glycine and 0.05% (v/v) Tween-20, referred to as 
the CTC releasing buffer. This CTC releasing buffer was carefully selected in large part 
for its relatively low conductivity (~50 µS/cm, pH 7.2) and the addition of trypsin to 
remove the bound CTCs from the capture channel surface for enumeration via single-
cell conductometric counting. 
3.2.5 Cell Suspensions. Citrated whole rabbit blood was purchased from Colorado 
Serum Company (Denver, CO). Upon collection, the blood was combined with 10% 
(w/w) sodium citrate to prevent coagulation. The MCF-7 cells (breast cancer cell line), 
growth media, phosphate buffered saline, trypsin, and fetal bovine serum was 
purchased from American Type Culture Collection (Manassas, VA). Adherent MCF-7 
cells were cultured to 80% confluence in Dulbecco’s modified Eagle’s Medium 
supplemented with high glucose containing 1.5 g L-1 sodium bicarbonate (NaHCO3), 15 
mM HEPES buffer, and 10% fetal bovine serum (FBS). A 0.25% trypsin solution was 
prepared in 150 mM PBS and used to harvest the MCF-7 cells.   
MCF-7 cells were stained with a fluorescein derivative, PKH67, containing a 
lipophilic membrane linker for fluorescence visualization experiments (Sigma-Aldrich, 
St. Louis, Mo). A modified protocol for cell staining was implemented whereby the dye 
concentration was increased 2-fold resulting in more evenly distributed fluorescent 
labels over the cell’s membrane. Cell counts for seeding experiments into whole blood 
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were determined by counting three aliquots of cells in succession using a 
hemacytometer. The cell count accuracy was within 10%.  
3.3 Results and Discussion 
3.3.1 Model CTC System. The MCF-7 cell line, used as a model for CTC selection and 
enumeration via the integrated HTMSU, is a breast cancer cell line that possesses an 
over-expressed membrane antigen termed the epithelial cell adhesion molecule, 
EpCAM.33-37 MCF-7 cells are typically 15 – 30 µm in diameter (mean = 24 μm) and have 
been closely associated with micrometastatic breast cancer.38  EpCAM occurs at a 
frequency of 5.1×105 molecules per cell.38  Monoclonal antibodies for EpCAM are 
available, which can be used to selectively speciate these cells from mixed populations.  
3.3.2 Major Considerations. A number of experimental and device operational 
parameters were investigated to optimize the performance of the HTMSU: (1) 
Throughput – linear flow velocity, pressure drops, processing time; (2) recovery – 
capture channel geometry (shape and width), and cell flow dynamics; (3) purity – 
designing surfaces to minimize non-specific adsorption and provide high selectivity for 
the target cells. 
3.3.3 Pressure Drop. Because the goal of the HTMSU was to process whole blood 
directly in a high throughput format requiring high volumetric flow rates to reduce 
processing time, we employed capture channels with high-aspect ratios (aspect ratio = 
channel height /channel width). For a capture channel width and height similar to the 
cell dimensions (aspect ratio = 1), capture of a cell within this channel would produce a 
large pressure drop due to blockage and possibly damage the captured cell making it 
unavailable for enumeration. Therefore, we adopted a capture channel geometry with 
an aspect ratio of 4.3; for a 35 µm channel width, the depth was 150 µm, which could 
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easily be replicated using hot embossing. From Equation 4.6 (see Chapter 4), and a 
blood viscosity of 4.8 cP (hematocrit = 0.4), the pressure drop for a channel 35 µm x 35 
µm (L = 3.5 cm) was calculated to be 7.4 x 103 Pa, while a channel that possessed 
dimensions of 35 µm x 150 µm had a pressure drop of 2.9 x 103 Pa, a reduction of 
greater than 60%.    
3.3.4 Flow Dynamics. It has been observed that laminar flow in a tube (capillary) 
having dimensions greater than 15% that of the cells being transported results in a 
marginal zone near the tube wall due to migration of the cells toward the central axis of 
the tube leaving a cell-free layer adjacent to the wall that can be as thick as 4 μm.39 
Because the capture elements (antibodies) are poised on the channel wall, this focusing 
effect can reduce the number of encounters between the CTCs and their recognition 
elements. To investigate this phenomenon, we imaged CTCs stained with a membrane-
specific fluorescein derivative as they were transported through an unmodified (no 
mAB) 35 µm wide microchannel that had a straight or sinusoidal configuration (see 
Figure 3.1). The results of these experiments are given in Figure 3.2; shown in the 
panels are the effects of channel shape and cell translational velocity (U) on the cells’ 
radial position within the microchannel. Evident in the linear channels (Figure 3.2A and 
3.2B) is a cell-free zone, similar to what has been observed in straight capillarie,40 
whose thickness increased with increases in U.  However, for the sinusoidally-shaped 
capture channels, CTC flow dynamics were quite different. First, there was no apparent 
marginal zone along one edge of the microchannel wall, and secondly, the cell radial 
distribution seemed to be unaffected by changes in U. The result would be an increase 
in the antigen/antibody encounter rate as the cells moved through the capture beds at 
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amounts of time using sinusoidal-shaped channels.   
igure 3.2 Histograms of the radial position of CTCs (centroid) in microchannels with 
Poiseuille flow at linear velocities (U) of 1.0 mm s-1 and 10 mm s-1 in both straight (A, B) 
the relatively high linear velocities required to process large input volumes in reasonable 
 





















Channel Radial Position (μm)
A

















Channel Radial Position (μm)

















Channel Radial Position (μm)




















Channel Radial Position (μm)
F
and sinusoidal-configured (C, D) channels. The dashed line represents the 
microchannel’s central axis. (A & B) The radial position of several CTCs histogrammed 
from micrographs of the straight microchannel with linear flow rates of 1 mm s-1 and 10 
mm s-1. (C & D) The radial position of several CTCs traversing ¼ of a period of the 
sinusoidal microchannels with suspension linear velocities of 1 mm s-1 and 10 mm s-1. 
The cells were imaged using fluorescence microscopy with the cells stained using a 
fluorescein lipophilic membrane dye, PKH67. 
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3.3.5 Effects of Channel Width and Linear Velocity on Capture Efficiency. In order 
to maximize the recovery of CTCs from whole blood, the dimensions and layout 
architecture of the capture channels and the linear flow velocity in which to operate the 
HTMSU were assessed. Experimental determinations of CTC capture efficiency using 
cell selection channel widths of 20, 35, and 50 µm (straight channels) were evaluated as 
well as a 35 µm wide capture channel adopting a sinusoidal pattern. The results of 
these studies are depicted in Figure 3.3A as plots of CTC capture efficiency (%) versus 
linear velocity, U (mm s-1).  
The 20 µm wide cha
estigated. Because the CTCs were often larger than this channel, the cell 
membranes were in constant proximity to the antibody-coated microchannel walls. Also, 
most CTCs when observed via fluorescence microscopy did not enter the capture 
channel because their size was larger than the channel width.  Those cells that were 
able to enter the selection bed, capture occurred within the first 1-2 mm of the 3.5 cm 
long channel. Due to these effects, the 20 μm device demonstrated consistent failure 
resulting from microchannel blockage. At higher linear flow velocities these blockages 
also led to compromising head pressures that resulted in device failure due to cover 
plate detachment from the embossed substrate. Therefore, adopting a channel width 
less than the cell average diameter was deemed inappropriate due to device failure and 
cell selection partly arising from size exclusion effects, which could lead to selection of a 
large number of leukocytes potentially complicating the enumeration process. 
Inspection of the data in Figure 3.3A for capture channels with widths gre
 average CTC cell diameter showed that the capture efficiency increased with 
increasing linear velocity for all channel widths and shapes until a critical value was 
reached (~2 mm s-1) at which point the capture efficiency decreased. For all capture 
channel widths and shapes when operated at the same linear velocity, improved 
capture efficiencies were obtained for narrower channels with the highest efficiency 




























Figure 3.3 Data showing the capture efficiency of CTCs as a function of the cells’ 
anslational velocity using 20 (black squares), 35 (red down triangles, sinusoid; purple 


























circles, straight), and 50 µm (blue up triangles) wide microchannels. (A) The microfluidic 
device consisted of a single channel with the appropriate width and a depth of 150 µm. 
Following processing of the input buffer containing the MCF-7 cells, the number of 
captured cells was determined via brightfield microscopy by interrogating the entire 
length of the capturing channel. (B) The capture efficiency data as a function of the CTC 
translational velocity was replotted using Equation 4.10 (see Chapter 4) with this data fit 
to        using the fitting parameter, kin (EpCAM:anti-EpCAM forward rate 
constant). Error bars represent the average 6 % variance in the capture efficiency. 








his latter observation was consistent with the focusing effects noted for cells moving in 
near velocity, we evaluated 
our
(3.1) 
where the first step (Equation 3.1) accounts for transport of the solution antigen to the 


























Figure 3.3B See caption above. 
 
T
a small channel experiencing laminar flow (see Figure 3.2). 
To understand the capture efficiency dependence on li
 data according to the Chang and Hammer model for cell adhesion between a 
surface-tethered antibody and a moving antigen.41 This model describes a two-state 
process; 
      
 (3.2)    
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ciency would exhaustively process 1 mL 
of input in 9.5 x 105 s (26 h). Simple increases in the linear velocity would not improve 
(Equation 3.2) gives the probability (P) that an association event will occur during the 
time the antigen is in close proximity to the tethered antibody. The encounter rate, ko, 
increases with increasing linear flow velocity while the probability of a reaction, P, 
decreases (see Figure 4.2 in Chapter 4). Analytical expressions for ko and P are 
provided in Chapter 4 based on the Chang/Hammer model.41  Below the cell 
translational velocity of 2 mm s-1, the capture efficiency is determined primarily by ko, 
but at U > 2 mm s-1, the capture rate is dominated by P. Plotted in Figure 3.3B is the cell 
adhesion rate, kads (see Equation 4.10 in Chapter 4) versus the cells’ translational 
velocity, which shows that kads asymptotically approaches a limiting value at 
translational velocities larger than 2 mm s-1. The data plotted in Figure 3.3B were then 
fit to the velocity-dependent intrinsic adhesion rate constant, kf, calculated from the 
product of ko and P (see Equation 4.7 in the Chapter 4) with one adjustable parameter, 
kin, which represents the forward rate constant between EpCAM and its anti-EpCAM 
antibody. Literature values for the MCF-7 cell line and the EpCAM:anti-EpCAM complex 
were used to calculate P (see Equation 4.9 in Chapter 4 as well as Table 3.1). The best 
fit was achieved for kin = 1 x 107 s-1, which is nearly two orders of magnitude larger than 
that reported in the literature for the EpCAM:anti-EpCAM forward rate constant (0.99 x 
105 s-1).42 This disparity was most likely due to cooperativity effects resulting from the 
high expression level of EpCAM in this cell line.43 In addition, the non-deformable nature 
of cell adhesion assumed in the Chang/Hammer model was not observed in the current 
experiments (see Figure 4.3 in the Chapter 4). 
A device with a single 35 x 150 µm channel operating at the optimal linear flow rate 




Figure 3.4 Time lapse micrographs of a captured MCF-7 cell: (A) Prior to exposure to 
the CTC releasing buffer; and (B) exposed to the CTC releasing buffer for ~10 min. (C) 
The cell appears to be released from the PMMA surface and finally, (D) the cell is swept 
away when the flow is initiated. 
 
 sampling throughput without sacrificing capture efficiency, so the device was 
designed to contain multiple capture channels of similar dimensions fanning from a 
common input. For example, with 51 capture channels, the processing time was 
reduced to 1.9 × 103 s (31 min). The common output for all of the capture channels 





ashing prior to cell counting used to quantitatively enumerate the number of captured 
the adhesion force for a single 
EpC
where r is the cell radius (12 µm for MCF-7 cells), η is the solution viscosity (4.8 cP for 
whole blood with a hematocrit level of 0.4) and  is the critical linear velocity that can 
induce cell detachment. Rearrangement of Equation 3.3 produced a value of 2.4 x 102 
3.3.6 Shear Effects on Captured Cells. It was necessary to evaluate shear forces 
induced by the fluid traveling through the channels during cell selection and device 
w
cells. Flow-induced shear could either detach the captured cells from the antibody-
decorated walls or damage the cell prior to counting.  
The total adhesion force (FA) between the cell and the antibody-decorated PMMA 
wall was evaluated using the model suggested by Bell.44 FA is derived from the product 
of the contact area, antibody surface density and 
AM:anti-EpCAM bond, fc (see Equation 4.12 in Chapter 4). The value determined 
for fc was 6.7 × 10-6 dynes (see Equation 4.14 in Chapter 4) with a contact area of 16.6 
µm2 for MCF-7 cells assuming the cells upon adhesion to the surface are non-
deformable (see Equation 4.13 in Chapter 4). Using these values and an anti-EpCAM 
antibody PMMA surface density of ~2.3 × 1011 cm-2 produced a total adhesion force of 
0.26 dynes.45 For cells that are flattened and elongated upon adhesion (see Figure 4.3 
in Chapter 4), the contact area was determined to be 456 μm2 and FA = 7.0 dynes 46. 
When the shear force (FS) generated by the laminar flow is equal to or greater than FA, 
the cell can be removed from the surface. The velocity dependent shear force, FS, was 
determined from Stokes’ law; 
6   (3.3) 
cm s-1 for  assuming non-deformable contact. Insertion of the contact area and FA for 




es were separated by 50 µm producing a cell constant, K 
Both of these values are significantly greater than the linear velocities used in the 
present experiments for optimizing the capture efficiency. Several captured cells were 
observed continuously during experiments in which linear velocities up to 10.0 cm
were implemented and no cell damage or disruption of cell:wall adhesion was detected. 
3.3.7 Detachment of Intact Cells for Quantitative Enumeration. Due to the strong 
adhesion force between the captured cells and the antibody-containing capture surface, 
thermodynamic release from the surface to allow for cell enumeration using the 
conductivity sensor was deemed in appropriate. The use of the proteolytic enzyme, 
trypsin, for the release of captured cells without causing cell disassembly, which would 
complicate single cell counting, was investigated. Figure 3.4 shows time-lapse 
micrographs of a surface-captured cell that was subjected to trypsin processing. 
Detachment was facilitated by the proteolytic enzyme in less than a 10 min incubation 
time. Rigorous evaluation of the trypsin release procedure indicated no cell damage 
was induced by this process. 
3.3.8 Conductivity Sensor for Cell Enumeration. Once the cells were released from 
the capture surface, they could be swept through the integrated Pt electrodes at the 
device output. The Pt electrod
(defined as the ratio of electrode gap to the electrode area), of ~0.01 µm-1. The cell 
constant was scaled to specifically detect CTCs due to their larger size with respect to 
leukocytes or erythrocytes. As shown in Figure 3.5A, the conductivity sensor with K = 
0.01 µm-1 did not transduce the presence of leukocytes or erythrocytes due to their 
smaller size and their characteristic electrical properties. This is particularly attractive, 
because any non-specific adsorption of leukocytes or erythrocytes during cell selection 
will not produce false positive signals providing an additional level of system specificity 



















Figure 3.5 Conductance responses (in arbitrary units, AU) and calibration plots for
CTCs are shown. (A) Conductometric response for suspensions of leukocytes and 
erythrocytes (cell density = 150 cells/µL) in TRIS-Glycine buffer transported through the 
integrated conductivity sensor at a volume flow rate of 0.05 µL/min. (B) Conductometric 


















response of a 1.0 mL aliquot of whole blood spiked with 10 ±1 CTCs and processed in 
the HTMSU at 2.0 mm/s. The isolated CTCs were released from the PMMA surface 
using the CTC releasing buffer and transported through the conductivity sensor at a 
volumetric flow rate of 0.05 µL/min. Peak identification was based on a signal-to-noise 
threshold of 3:1, which was determined by the peak height of the apparent response 
and the average peak-to-peak variation in the conductance of the CTC releasing buffer. 
The arrows designate those peaks scored as CTCs based on the aforementioned 
criteria. The arrow marked with an “x” possessed a conductivity response lower than the 
background buffer and as such was not scored as a CTC. (C) Calibration plot for the 
number of CTCs seeded (10 – 250 cells mL-1) into whole blood versus the conductance 
responses registered using the conductivity sensor following the processing steps 
delineated in Figure 3.5B (m=0.945, r2=0.9988). The data presented in Figure 3.5B was 
























Figure 3.5 (B and C) See caption above. 
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ollowing antibody-mediated capture of CTCs seeded into whole blood using the 
HTMSU, the cells were released from the surface and hydrodynamically driven through 
the contact conductivity sensor.32 The chemical composition of CTCs make them idea
candidates for detection using conductivity due to their unique electrical properties
compared to erythrocytes or leukocytes. For example, CTCs in general possess very 
low membrane potential and low impedance resulting from the intracellular migration o
sodium ions (Na+) in compensation for the depleted potassium ion concentration (K
the intracellular fluid. Also, alteration in the cancer cell’s membrane content with respec
to the types of glycoproteins and antigens they express result in an increase in th
number of negatively charged sialic acid molecules that cap the extracellular domains of 
many
W
 integral membrane proteins.47 
e next analyzed 1 mL of whole blood seeded with 10 ±1 CTCs using the HTMSU,
released the enriched cells and quantitatively counted them with the conductivity sensor
(see Figure 3.5B). Based on a signal-to-noise threshold of 3 (99.7% confidence lev
there were 8 peaks in the conductance trace shown in Figure 3.5B that were assigned
to CTCs. As can be seen from Figure 3.5B, only positive conductance spikes wer
scored as CTCs, while negative spikes were not scored as CTCs.  The CTC scoring 
system was verified through brightfield microscopy, which indicated that CTCs produced
positive signals relative to the background conductance generated by the CTC releas
buffer and the negative signals were produced from particulates. In addition, careful
microscopic inspection indicated that the positive conductance spikes were indeed due 
to single cells. The disparity in the peak response for single CTCs was due to 
ifferences in cell morphology and composition partly resulting from any one of five d




ere evaluated (see Figure 3.5C). The best fit line 
to t
to specifically detect the CTCs using an 
For proper enumeration of the recovered CTCs using the HTMSU, the readout 
phase of the assay required a sampling efficiency near 100% so that every cell released 
from the capture channels could be detected with sufficient signal-to-noise to be scored 
as a CTC. To accomplish this and keep the conductivity cell constant (K) at a sufficient 
level to provide high signal-to-noise for the CTCs, the HTMSU was designed with a 
multi-level architecture (see Figure 3.1E). The 150 µm deep capture channels were 
tapered to a depth of ~80 µm at the conductivity sensor to match the Pt electrode 
diameter to ensure a sampling efficiency near 100%. 
To verify the recovery and detection efficiency of the system, the seed number of CTCs 
in whole blood versus the number of cells enumerated over a broad physiologically-
relevant range (10-250 CTCs mL-1) w
hese data indicated a slope of this calibration curve of 0.945 with an intercept near 0 
(r2 = 0.9988), indicating near 100% recovery and detection of the CTCs seeded into 
these samples using the HTMSU. 
3.4 Conclusions 
A novel polymer-based HTMSU was designed, fabricated, and tested for selecting, 
with high efficiency and specificity, CTCs directly from whole blood using surface-
immobilized monoclonal antibodies targeted for membrane proteins unique to this class 
of cells. Due to the simple and low-cost production of these devices using micro-
replication technologies as well as their automated operation with no sample pre-
processing required, the HTMSU can be envisioned as an important diagnostic tool for 
monitoring CTC levels in a variety of adenoma-based cancers for disease detection, 
cancer staging or evaluating the effectiveness of therapeutic intervention. A compelling 





bility to process 1 mL of input in 
n as well with the ability to change the molecular 
nt to target other rare cells. For example, E. coli O157:H7 is a 
bac
grated conductivity sensor. The sensing platform did not respond to potential 
interferences, which could give rise to false-positive signals, and was simple to 
implement both operationally (no cell staining as required for fluorescence) and 
instrumentally (no optical microscope or flow cytometer was required). 
The HTMSU was designed to process large input volumes to search for rare events 
using molecular recognition via integral membrane proteins specific for the target. High 
throughput processing was realized by using a number of high-aspect ratio 
microchannels configured in parallel, providing the a
~30 min. If the channel depth was increased to 250 – an aspect ratio of 7.14 for 35 μm 
wide channels – and the number of parallel channels doubled, the sampling time for this 
same volume input could be reduced to 2.7 min. These changes could provide the 
ability to select extremely rare events requiring the need for processing larger input 
volumes (>10 mL). 
The HTMSU is flexible in functio
recognition eleme
terial species typically found in a variety of fresh water bodies with EPA acceptable 
colony forming unit levels of <20 in waste water and <200 in lakes and rivers per 100 
mL. Using monoclonal antibodies specific for this bacterium and scaling the capture 
channel widths and conductivity sensor appropriate for these cell types, the reported 
device can be envisioned for field deployment to provide timely results for assisting in 
bacterial containment.  
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Chapter 4 Theory, Models, and Expansion of Highly Efficient Circulating Tumor 
Cell Isolation from Whole Blood and Label-free Enumeration Using Polymer-
Based Microfluidics with an Integrated Conductivity Sensor* 
 
4.1 Conductivity Detection Electronics 
 To measure conductance changes in the CTC releasing buffer of the HTMSU 
induced by single CTCs, a specially-designed circuit was developed (see Figure 4.1). 
To reduce the effects of parasitic capacitance, Cp, due to wiring and the electrode 
configuration, a synthetic inductor, L, of 132 mH was designed using a gyrator circuit. 
Gyrators, for a given bandwidth, allow the creation of high Q inductors from RC 
components. This inductance was placed in parallel with Cp and the sine frequency 
varied to locate the resonance peak of the voltage across L and Cp. Once this 
resonance point was found, the voltage across the sample cell was directly sensitive to 
changes in Gs (solution conductance). A target frequency of 40 kHz was chosen to 
minimize the impedance due to Cd (double layer capacitance) and hold the inductance 
to a reasonable value. This signal was fed to a transconductance amplifier, G1, which 
converted the voltage sinusoid into a current. The gain of G1 was 10 μA/volt. A current 
source was needed to drive the sample cell because a voltage source, with its low 
output impedance, would reduce the circuit’s Q. The current was set to ±5 µA for the 
experiments. The required resonance frequency (f) could be approximated by the 
standard parallel resonance equation;  
  (4.1) 
The voltage across the sample cell was fed to an Analog Devices AD630 synchronous 
modulator/demodulator (Norwood, MA) that was configured as a phase sensitive 
detector. The reference input of the AD630 was driven from a phase-delayed sine wave  
oscillator output. This phase adjustment was needed to compensate for phase lags in 
the detected sample voltage. The sample voltage was fed to a low pass filter with a 
cutoff frequency of 180 Hz. The filter produced an average dc signal that was sent to a 
differencing amplifier, A1. The difference amplifier served to null the output to zero volts 
while measuring GS. A high gain amplifier, A2, could amplify small changes in GS without 
saturating the voltage produced by the releasing buffer itself. A National Instruments 
PCI6071E, 12 bit A/D acquisition card (Austin, TX) was used to convert the analog 
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4.2 Pressure Drop in a Microchannel with Blood Flow 
 The volume flow of blood (Q) in an enclosed microchannel can be calculated from a 





  (4.2) 
The hydraulic diameter of the microchannel (d) is given as , 
where A is the channel cross-sectional area and ht and w represent the channel height 
and width, respectively,  is the solution viscosity,  is the pressure drop (see 
below) and  is calculated from; 
/
 
  (4.3) 
The term  accounts for the viscosity-dependent hematocrit level of whole blood 
with  determined from Equation 3.A4; 
·
  0.1 · 0.625
∆  
   (4.4) 
where  is the yield stress and is related to the blood hematocrit level (H) using; 
  (4.5) 
From Equation 4.2, the pressure drop (∆ ) in a channel of length L can be calculated 
from; 
  (4.6) 
4.3 Modeling Cell Capture Data as a Function of the Cell Translational Velocity (U)  
 To explain the experimental data in terms of capture efficiency versus the linear flow 
rate, the data for the 35 µm wide sinusoidally-shaped channels was modeled by 
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transport was dominated by convection (i.e., Pe >> 1, where Pe is the Peclet number 
and represents the ratio of convective to diffusive mass transport).1 In this model, the 
rate of capture of cells at a surface containing immobilized recognition elements 
depends on the encounter rate and the reaction time. The rate of capture per 
ligand/receptor pair (kf, s-1) can be calculated with Equation 3.A7; 
     (4.7) 
where ko is the encounter rate and describes the rate of transport of cells to the wall 
where the antibodies are immobilized and P is the probability of a reaction occurring 
between the cell ligand (i.e., EpCAM) and surface receptor. For Pe >> 1, as in the 
current experiments, kf is primarily reaction limited and is calculated using Equation 4.8; 
     (4.8) 
where D is the cell diffusion coefficient and Nu is the Nusselt number, which describes 
the flux of antigens to immobilized antibodies and can be approximated from 2  for 
Pe >> 1. P is estimated from Equation 4.9; 
  (4.9) 
where  is the dimensionless Damköhler number ( ; kin = intrinsic EpCAM:anti-
EpCAM reaction rate; a is the encounter radius) and Λ is the dimensionless encounter 
time and is calculated from / , where . A plot of ko, P, and kf 
versus the cell slip velocity, where the slip velocity is ~0.47U, are depicted in Figure 4.2.  
 The experimental data (% of input cells bound to the channel wall) can be used to 
calculate the rate of adsorption, kads, from; 




where L is the length of the capture channel and U is the translational velocity of the 
cells within the fluidic channel. Finally, kads is related to kf through the relationship; 
  (4.11) 
where  is the cell surface antigen density and  is the number of antibodies in the 
encounter area (2 ).  Therefore, a plot of  versus , which is obtained from the 
experimental data, can be fit to Equation 4.8 with one adjustable parameter, kin, that is 
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Figure 4.2 Plot of P (black rectangles), ko (red circles) and kf (blue triangles) as a 














Figure 4.3 Brightfield and fluorescence micrographs showing monoclonal antibody 
captured CTCs in a PMMA microchannel. (A) Brightfield micrographs taken at 40× 
magnification and (B) the corresponding fluorescence micrographs verifying the 
captured cell is the fluorescently labeled CTC. The inset shown in Panel (A) is a 
fluorescently-stained MCF-7 cell in a PMMA channel that was not decorated with anti-




4.4 Adhesion Strength of EpCAM:Anti-EpCAM Antibody Complex on a Surface 
 The adhesion force ( ) between the cell and the antibody-decorated surface can be 
determined from the bond strength between a single antigen:antibody complex ( ), the 
119 
 
       
     sin 
 
cell contact area with the PMMA surface ( ) and the number of receptors poised on 
the PMMA surface within the contact area of the cell ( ) from: 
   (4.12) 
If the cell is assumed to be a non-deformable object upon adhesion to the capture 
surface, the contact area can be calculated using Equation 4.13;2 
    (4.13) 
where r is the cell radius and h and h' represent the characteristic cell separation 
distances from the surface upon binding. Using h and h' as 100 Å and 400 Å, 
respectively,3 the calculated contact area was determined to be 16.6 µm2 for the MCF-7 
cells. If the cell is assumed to flatten and elongate after contact, as observed 
experimentally (see Figure 4.3), the resulting contact area Ac is 456 µm2.4 
The single EpCAM:anti-EpCAM antibody adhesion force was estimated using the 
formalism by Bell,5 who developed the following expression for deriving the critical force 
required to break a single bond (Equation 4.14); 
  (4.14) 
where k is Boltzman’s constant, T is the absolute temperature, ro is the separation 
distance between receptors at the minimum breaking force and  (K = 
EpCAM:anti-EpCAM equilibrium constant). Using values from Table 3.1 and T = 298K, 
a value of 6.7 x 10-6 dynes was calculated for . The same result was found using 





Table 4.1 Literature values for the complex between EpCAM and its monoclonal 
antibody. 
Parameter Description Value Reference
 Encounter radius 5 nm 1 
 Forward rate constant for EpCAM - anti-
EpCAM binding  
0.99 x 105 s-1 8 
 MCF-7 average cell radius  12 µm 9 
 Blood hematocrit level  0.4 10 
 Cell selection bed length 35 mm  
 Microchannel hydraulic number  56 µm 11 
 MCF-7 cell diffusion coefficient 10-10 cm2 s-1 12 
 Viscosity of blood (H = 0.4)  4.8 cP 10 
 Cell surface density of EpCAM - 
calculated from the average surface 
area of MCF-7 cells and the expression 
282 µm
level of EpCAM  
-2 13 
 Expression level of EpCAM in MCF-7 
cells  
5.1 x 105 13 
 EpCAM:anti-EpCAM equilibrium 
constant  
3.3 x 108 M-1 8 
 Separation distance between receptors 0.5 nm 
at min. breaking force  
1 
NL Substratum anti-EpCAM density on UV-
modified PMMA  
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Chapter 5 Highly Specific Selection, Isolation, and Enumeration of Escherichia 
coli from Various Water Sources 
 
5.1 Introduction 
Escherichia coli (E. coli) are potentially enterohemorrhagic bacteria living in the 
lower intestines of many mammals, and are typically known as gut flora. Their primary 
function, when located in the intestines, is assisting in waste processing, vitamin K 
production and food absorption. There are several hundred strains of E. coli; strains like 
E. coli O157:H7 produce powerful “shiga-like” toxins (stx1, stx2) responsible for severe 
illnesses including but not limited to bloody diarrhea, colitis, or even death in animals 
and humans.1 E. coli O157:H7 also harbors a 43 kb pathogenicity island, termed the 
locus of enterocyte effacement, which contains virulent attributes required for forming 
lesions on hosts. Hemolytic-uremic syndrome (HUS) and seizures are presented in 
infantile cases resulting from exposure of these pathogens to children.2 Physically, E. 
coli is a rod-shaped bacterial cell with a length of 2 µm and a width of approximately 0.8 
µm. In many cases, E. coli infiltrate various fresh water bodies by being carried via 
runoff to tributaries and/or aquifers.3 These virulent bacteria are typically transmitted via 
the fecal-oral pathway by ingesting contaminated water or food-stuffs.4  
The food industry is particularly concerned with cross-contamination due to the 
proximity of many domestic farm animals to various vegetative food crops in rural areas. 
The turn-around time for laboratory tests often exceeds 2 wk.5 Thus, it has become 
increasingly necessary to screen for these bacteria earlier in the food production cycle 
in order to reduce the numerous potential health-related issues associated with 
widespread outbreaks. To decrease the impact, implementation of testing at the earliest 
possible point of intervention is required. Minimization of the scope of the impact from 
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such contaminations is inextricably linked to developing portable, sensitive, isolation 
and enumeration technologies that can be effectively applied by novice end-users. 
A common strategy employed for determining the presence of E. coli is the ISO 
9308-1 method in which water samples are membrane filtrated followed by the growth 
of the isolated cells using lactose 2,3,5-triphenyltetrazoliumchloride (TTC) agar with 
Tergitol 7.6 Coliforms reduce TTC producing a yellow-orange color indicative of rod-
shaped bacteria that ferment lactose to produce gas and acid within 48 h at 35°C.7 
However, the major difficulties associated with this methodology are the time required to 
produce readable results, and the ability for a broad cross-section of users to correctly 
interpret the results. In addition, other organisms present in the water can elicit a 
positive response (false positive for E. coli) and some E. coli strains do not ferment 
lactose (false negatives).8 A recent comparison of different growth media for culturing E. 
coli and various coliforms was presented.9 The results of the comparison study 
indicated that m-ColiBlu24 and Colilert 18 chromogenic media provided faster and more 
reliable results compared to the ISO standard media, but still required 22 h and 18 h, 
respectively, to obtain reliable results compared to 72 h for the ISO 9308-1 method. 
 A recent report highlighted the ability of a molecular biological assay, BAX, to detect 
and enumerate the presence of E. coli O157:H7 bacteria.10 In this assay, the 
capabilities of real time polymerase chain reaction (RT-PCR) are used to specifically 
test for strain-specific species using molecular markers unique to the strain. The authors 
reported the ability to detect 10 CFUs in a processing time of 8 h, where CFU is defined 
as “colony forming unit,” which is the number of viable bacteria. However, the process 
required pre-concentration of samples containing low abundances of E. coli by filtering 
the water sample using 0.45 µm cellulose ester filters followed by elution of the retained 
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material. Then, the eluted volume was subjected to immunomagnetic selection using 
anti-E. coli O157:H7 antibodies coated onto magnetic beads. Unfortunately, these 
multiple processing steps made implementation of this assay for field deployment 
prohibitive due to the extensive hardware requirements and the required operator 
expertise. Though these virulent bacteria, impose imminent danger upon consumption 
there exists no U.S. Food and Drug Administration mandate on maximum levels in any 
food source.11 The total bacterial level at which action is taken by the FDA is currently 
set at 104 CFU g-1 of sample (see Table 5.1). 
 Recreational waters including fisheries, boating, and swimming areas as well as 
drinking water supplies have in recent years become breeding grounds for potentially 
virulent bacteria.1 The US EPA allowable levels of E. coli are shown in Table 5.1. 
Specifically, elevated levels of pathogenic bacteria such as E. coli O157:H7 can be 
correlated to the increased occurrence of most water-related sicknesses, deaths, and/or 
the development of harmful algal bloom formations.12 These waterborne pathogens are 
assessed by first filtering large (100 mL) aliquots of water using porous membrane-
based filter paper that can also support the subsequent adherent cell culturing and 
microscopic inspection of the bacteria such that a determination can be made as to 
viability and toxicity. Upon harvesting and culturing the bacteria, morphological 
examinations as well as pathogen specific immunoaffinity is often used. 
 There are a variety of emerging technologies for isolating cells from heterogeneous 
samples with selection based on immunoaffinity or distinct reporter molecules that are 
unique to the targets. The most promising developments include fluorescence assisted 
cell sorters,1 flow through filtrations,13,14 enzyme linked immunosorbent assays 
(ELISA),15,16 and immunomagnetic cell sorting.17-19 The commonality between these 
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methods is the extensive use of prefiltration and arduous culturing protocols needed to 
produce detectable levels of the bacteria. The most rapid of these assays can take up to 
8 h. In addition, the required equipment and sample preparation phases of these assays 
make them difficult to implement for wide-scale usage, especially in field-deployable 
applications. 
 
Table 5.1 Source and acceptable levels of E. coli 
Source Acceptable E. coli level, CFU/100 mL 
Drinking20 0 
Wastewater20 20 
Lake/River20 200(A) 1000(C)* 
Meat/Produce21 104** 
*(A)=Advisory **(C)=Closure. **Represents CFU g-1 which is the FDA action level. 
 
In order to successfully analyze rare bacterial strains in complex samples, new 
approaches are required. The ideal system would provide high specificity for selection 
of the species/strain/source specific bacteria directly from waters or other complex 
sample matrices from a variety of sources and also enumerate the number of colony 
forming units (CFU) over a large dynamic range. The system should be simple to 
operate and packaged into a compact unit that will permit field deployment. The 
following characteristics should be associated with the device; (i) high throughput 
sampling of mL volumes in <10 min of processing time concentrating the bacterial cells 
to nL volumes; (ii) functionally compatible with immobilization strategies used to fix 
capture elements to the capture bed; and (iii) amenable to small sensors with high 
sampling efficiency for automated cell counting strategies. In any case, the volume 
sampled is typically dictated by the frequency of the events to be assessed.  For 
bacteria the US EPA recommends aqueous sample sizes of 100 mL20 and the US FDA 
recommends solid samples sizes of 25 g.4  
Traditional microfluidic device architectures are encumbered by inherently low 
throughput; however, when parallelization of features is employed, as in the design 
delineated herein, it is possible to exhaustively interrogate large samples for rare 
biological cells in short periods of time (see Fig. 5.1). In this manuscript, we present 
preliminary results on the use of a novel technology directed toward the unambiguous 
identification of microbial water supply contaminates using microfluidic devices that 






Figure 5.1 AutoCAD 2008 rendering of a microfluidic device that can provide high 
throughput miscro-sampling (HTMSU). The device used a series of microchannels that 
were decorated with antibodies specific for the target cell. The antibodies were 
immobilized beneath the gray shaded region, which consisted of 37 straight 
microchannels that were uniformly 3 cm long and 30 µm wide. The entire device was 
150 µm deep. The output end contained a conductivity sensor that consisted of a pair of 




5.2 Materials and Methods 
5.2.1 High-Throughput Microsampling Unit Fabrication. The substrate selected for 
the high throughput micro-sampling unit (HTMSU) was poly(methyl methacrylate), 
PMMA, due to its high fidelity for forming structures with high-aspect ratios via micro-
replication, minimal non-specific adsorption of E. coli cells to its surface and its ability to 
generate functional surface-scaffolds through UV irradiation for the attachment of a 
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variety of biological moieties.22 A molding tool was made via high precison micromilling 
and the molding tool used to emboss microstructures into PMMA. Embossed PMMA 
substrates and PMMA cover slips were cleaned with reagent grade isopropyl alcohol 
(Sigma-Aldrich, St. Louis, MO), rinsed with nanopure H2O (Model D8991, 
BarnStead/Thermolyne, Dubuque, IA), sonicated with a model 8890 sonicator (Cole 
Parmer, Vernon Hills, IL) for 15 min, rinsed with IPA again, and air dried. Then, 
ultraviolet (UV) modification of the PMMA substrates and cover slips was performed 
through an aluminum mask to facilitate the formation of carboxylic functional groups on 
the PMMA surface for antibody immobilization. Both substrates and cover slips were 
irradiated at 254 nm with 15 mW cm-2 for 10 min from the UV source (500W DUV; 
Model UXM-501 MA; Ushio America, Cypress, CA). After UV modification, the glass 
transition temperature (Tg) of the substrate was changed from 106 °C to 101°C.23 The 
microdevice and cover slips were aligned and clamped between two glass plates and 
fixed using clips (ACCO Brands, Inc., Lincolnshire, IL). The UV modified areas of the 
device and cover slips were mated using alignment marks. The clamped unit was then 
inserted into a programmable oven (Varian 3400, Palo Alto, CA) and the temperature 
raised from 50°C to 101°C at a rate of 20°C/min with the final temperature held for 15 
min. The total annealing time for each HTMSU was 17.6 min. A 15 cm long (inlet) and a 
2 cm long (outlet), 237µm O.D. and 100 µm I.D. polyimide coated fused silica capillary 
(Polymicro Technologies, Ave Phoenix, AZ) was epoxied between the substrate and 
cover slip on the inlet and outlet sides of the HTMSU, respectively. An AutoCAD 
rendering of the device is shown in Figure 5.1. 
5.2.2 Antibody Immobilization. The HTMSUs were loaded with 4 mg mL-1 of 1-ethyl-3-
[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) and 6 mg mL-1 of N-
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hydroxysuccinimide (NHS) in 150 mM 2-(4-morpholino)-ethane sulfonic acid (MES) 
(Sigma-Aldrich, St. Louis, MO) at pH 6 for 1 h at room temperature to obtain the 
succinimidyl ester intermediate of the carboxylated surface. The EDC/NHS solution was 
removed by rinsing the fluidic network with nanopure H2O. Then, an aliquot of 1.0 mg 
mL-1 of affinity purified polyclonal anti-E. coli O157:H7 antibody (K-log, Inc., 
Gaithersburg, MD) solution in 150 mM PBS (pH=7.4) (Sigma-Aldrich, St. Louis, MO) 
was introduced into the HTMSU and allowed to react for 4 h.  
5.2.3 Cell Suspension. E. coli O157:H7 cells were purchased from K-log, Inc., 
Gaithersburg, MD. The E. coli cells were stained with FITC using a lipophilic membrane 
linker (PKH67, Sigma-Aldrich, St. Louis, MO). The cell density of the original E. coli 
O157:H7 sample was 3 x 109 cells mL-1. Serial dilutions were performed to obtain the 
desired cell density for each experiment.  
5.2.4 Cell Capture Protocol. The HTMSUs were fixed onto the programmable 
motorized stage of an Axiovert  200M (Carl Zeiss, Thornwood, NY) microscope and 
videos were captured during each experiment at 30 frames per second (fps) using a 
monochrome CCD camera (JAI CV252, San Jose, CA). A  Xe arc lamp was used to 
excite the fluorescent dyes incorporated into the cell membrane. A syringe pump was 
used in an infuse mode to inject cell suspensions and buffers into the HTMSU. The 
HTMSU was interfaced to a syringe pump (Model PHD2000, Harvard Apparatus, 
Holliston, MA) using a syringe (Becton, Dickinson, and Company, Franklin Lakes, NJ) 
and luer-to-CE adapter (InnovaQuartz, Phoenix, AZ). Pre-capture rinses were 
performed with 0.2 mL of 150 mM PBS at 20 µL/min flow rates (270 mm s-1) to maintain 
isotonic conditions. Then, 0.1 mL of a 10 cells µL-1 cell suspension was introduced at 




mM PBS at 100 mm s-1 to remove non-specifically adsorbed cells on the HTMSU 
surface. Finally, the numbers of cells captured by the antibody immobilized 
microchannels were counted using brightfield and fluorescence microscopy for 
confirmation of cell capture to the channel walls. Each experiment was performed in 
triplicate for each linear velocity studied. 
5.3 Results and Discussion 
 Microdevices with 30 µm wide channels that were 150 µm deep and 3 cm long were 
used to assess the capture efficiency of the antibody-immobilized microfluidic device for 
cylindrically-shaped E. coli cells (0.8 µm dia. × 2.0 µm long) from 10 µL suspensions 
with densities of 100 E. coli cells µL-1. In order to determine if the antibody was 
covalently tethered to the microchannel walls, fluorescently labeled antibodies were 
used. In Figure 5.2, the fluorescence intensity from a microchannel with no labeled 
secondary antibody, a microchannel loaded with 500 µg mL-1 anti-E. coli O157:H7 
secondary antibody (K-log, Inc., Gaithersburg, MD), and a rinsed microchannel with 
secondary antibody are shown. From these images, it was found that a buffer rinse 
following antibody immobilization resulted in an increase in the average fluorescence 
above background, strongly indicating the presence of tethered antibodies.  
 Experiments were next conducted in which E. coli strain K12 was used as a 
negative control. Due to genomic differences, strain K12 lacks the capacity to express 
the antigen targeted by the anti-E. coli O157:H7 antibody. As expected no E. coli K12 
cells were isolated using this microfluidic device with O157:H7 antibodies (see Figure 
5.3). In addition, the lack of K12 cells adsorbed to the channel wall provided evidence of 
a lack of non-specific adsorption of these cells to the channel wall.  























Immobilized Anti-E. coli Ab
 
Figure 5.2 Fluorescence image of a 20 µm wide microchannel decorated with surface-
immobilized antibodies that were covalently labeled with a fluorophore. The control 
trace, illustrated by a black dotted line, shows the PMMA microchannel in the absence 
of the fluorescently-labeled antibody. The solid blue line represents the fully loaded 
channel after it was infused with a solution containing 500 µg mL-1 of FITC labeled anti-
E. coli antibody in the presence of EDC/NHS. The red dashed trace shows an increase 
in the fluorescence intensity corresponding to the immobilized antibody immobilized. 
The two solid black lines represent the average fluorescence intensity before and after 
the immobilization process. 
 
 
Finally, the target O157:H7 cells were processed through the antibody immobilized 
HTMSU. Fluorescently-labeled O157:H7 cells were selectively isolated from 
suspensions at a 2.0 mm s-1 linear velocity. After processing 10 µL of the sample, the 
captured cells were enumerated via fluorescence microscopy. The capture efficiencies 
in three successive experiments was found to be 5.3%, 6.1%, and 8.7%. The low 
capture efficiency can be attributed to the relatively wide linear microchannels used 
here with respect to the width of these cells. The diameter of the E. coli cells was 0.8 
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µm and the channel width used was >20× that of the targets. We have previously 
shown, that by designing the capture microchannel width to dimensions similar to that of 






Figure 5.3 A) The micrograph shows 9 captured E. coli O157:H7 cells indicated by 
arrows. The cells were isolated from a suspension with cell density of 100 E. coli 
cells/µL using an antibody immobilized microdevice. B) The panel shows that no E. coli 
strain K12 cells were isolated when a suspension of equal density of the innocuous 
strain was analyzed. 
 
In addition, previous experiments indicated that linear microchannels are not ideal 
for capturing cells, because the cell trajectories are parallel to the microchannel walls 
with cell focusing resulting from hydrodynamic effects resulting in low numbers of “cell-
wall” interactions producing fewer capture events. Incorporating curvilinear 
microchannels can further increase the recovery due in large part to the inertia of the 
cells, imparted by centripetal forces resulting from traversing the curved region of the 
microchannels.  
5.4 Conclusion 
 A new approach toward the isolation of low abundant E. coli cells has been 
presented in which the number of cells in mL-scaled samples can be ascertained 




result in analysis times exceeding 48 hrs. The E. coli O157:H7 cells were specifically 
indentified and immobilized using immunoaffinity. Further investigations are warranted 
for the capture and enumeration of E. coli cells to increase the capture efficiency and 
provide the ability to sample larger volumes in minimal processing times. Micromilling 
has proven effective in producing devices with multilevel structures for circulating tumor 
cell isolation and enumeration,24 yet as evidenced by the low capture efficiencies 
presented here, this fabrication technique is not suitable for producing architecture 
appropriate for E. coli isolation. The maximum capture efficiencies in the devices 
presented herein are limited due to the minimum channel widths (~20 µm) that 
micromilling is commensurate with producing. Future efforts should focus on 
engineering microdevice designs specifically for E. coli. To improve upon capture 
efficiency, it would be suggested to produce devices with a maximum width of 2 µm and 
depth of 40 µm corresponding to a minimum aspect ratio of 20, an aspect ratio that can 
be used to replicate parts in polymers using embossing. Using these parameters, x-ray 
lithography is ideally suited for production of moulding tools containing these narrow 
and deep channels required for effective E. coli isolation. In addition, to increase 
throughput thereby reducing analysis time the number of parallel processing channels 
should be increased.  For example, the use of 2,000 parallel channels would allow for a 
volume flow rate of 19.2 µL min-1 maintaining a linear velocity of 2 mm s-1 to maximize 
capture efficiency through the selection channels of the device and producing a 1 mL 
processing time of 52 min. If the aspect ratio of this device were doubled while 
maintaining the channel width, the throughput would also double thereby reducing the 
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Chapter 6 Future Work: Continued Biosensor Research at United States Naval 
Research Laboratory, Washington D.C. 
 
6.1 Introduction 
 Explosives pose major security and environmental risk in this era of immanent 
domestic terroristic activity.1 In addition, the existence of explosive nitroaromatics such 
as TNT at various military sites and munitions testing grounds throughout the United 
States require environmental monitoring of residual unexploded ordnance as well as the 
degradation products of detonated nitroaromatics in groundwater and soil.2 Finally, 
forensic investigations, as they pertain to domestic terroristic activities, also dictate that 
field deployable assessment tools be readily available for untrained field technicians to 
employ in order to rapidly determine the safety of emergency medical personnel and 
other first responders.2  
 Off-site chemical analysis has been performed using traditional instrumentation 
including high performance liquid chromatography,3 gas chromatography coupled to 
mass spectrometers,4 surface enhanced Raman spectroscopy,5 cyclic voltammetry,6 
and energy dispersive x-ray diffraction7 in the analysis of various explosives. These 
methods have successfully delivered high sensitivity and selectivity for the analytes yet 
these methods offer limited portability which detracts from their potential for being field 
deployable. Size notwithstanding, these instruments further require the significant 
expertise to employ. Microarray biosensors that involve the displacement of analogues 
have been employed in the field with promising results, but the traditional mass 
transport limitations in conventional microarrays and microfluidics inhibit the ability to 
reliably detect sub-pg/mL amounts of the analytes from bulk solution reliably.1 To date, 
the most prolific field deployable detection system has been the extensively trained 
canine, but unfortunately, these animals are expensive, require continuous 
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maintenance, and are subject to fatigue. Further, the canine’s strong sense of smell is 
rendered ineffective when the analyte or target is submerged in groundwater.2 
 The nature of explosives and concern for the safety of the analyst or sample 
collector suggest the need for sensing these dangerous and potentially toxic (≥ 2 
ng/mL) environmental contaminants remotely.8 This is especially important in the cases 
where the analytes consist of plumes of unexploded ordnance that has the potential for 
accidental detonation. Therefore, sensors for explosive nitroaromatic compounds that 
offer new approaches to the rapid, highly sensitive and selective remote detection of 
trace levels of various explosives are warranted. Proposed herein is a novel approach 
with application of high aspect ratio microstructures designed to meet three primary 
requirements: 1) reduction of false positive and false negative responses in complex 
matrices, 2) rapid analysis time, and 3) capable of sampling large volumes. 
6.2 Materials and Methods 
6.2.1 Apparatus and Protocol. Three peristaltic pumps (Lee Company, Westbrook, 
CT) connected to high aspect ratio microfluidics via fused silica capillaries will be 
employed to hydrodynamically infuse/effuse samples, regenerate fluorescent surface, 
and wash the antibody coated device. The custom pumps are designed expressly to be 
incorporated into field deployable portable devices employing microfluidics as indicated 
by the design incorporating a small rugged outer casing, low power consumption, 
capability of delivering as low as 0.1 μL per step, and five hundred total steps for all 
chamber volumes. The pumps have 0.25 ms response times and can be configured 
with chambers that range from 10 μL – 1.25 mL. The pumps also allow solution pass 
through, when the pumps metering piston is in the full open position, to vent or send 
processed components to waste vessels. Each pump has a vent system designated V1, 
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V2, and V3 that corresponds to each pumps designation P1 through P3. Two of these 
pumps (P1 and P2) will be connected to the inlet side of a Y oriented interface designed 
to accommodate two feeding capillaries with P1 dedicated to delivering the fluorescently 
labeled analogues, surface regeneration, that adsorb to the antibody immobilized 
surfaces aiding the establishment of a baseline fluorescence signal from which 
displaced fluorescence corresponds to bound target.1 P2 on the inlet side of the device 
will be used to sample the ambient environment of the system on command in 
conjunction with P3 which is connected to the effluent side of the microsampling unit. 
With P2 in the open position P3 will be actuated instituting uptake of the sample. In 
order to interface the pumps to the high throughput microsampling unit (HTMSU), a 
PEEK-to-capillary (Hamilton, Reno, NV) adapter kit will be fitted with a luer-to-capillary 
adapter (InnovaQuartz, Phoenix, AZ). The pumping system will be designed to generate 
the appropriate volume flow rate to quantitate TNT over a broad linear dynamic range of 
relevant (subpicomolar – nanomolar)) TNT plume concentrations. The capture efficiency 
on an antigen flowing over a bed of immobilized antibodies has been shown to be 
dependent of the flow rate and the length of column used.9-11 Also critical is the size of 
the capture bed. In earlier experiments, the amount of antibody bound to a fixed surface 
increased with increases in capture bed size. Also observed in these experiments was a 
decrease in the %RSD of measurements in which more analyte was obtained and 
quantitated implying improvement in measurement precision can be achieved when 
isolating more analyte.9,10  
The high throughput microsampling unit (HTMSU) will be fixed to the stage of an 
inverted microscope initially, allowing for monitoring the release and/or adsorption of the 
chromophores to the HTMSU using fluorescence imaging via a high sensitivity CCD 
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A CCD would be employed in the displacement based assay to monitor the loss of 
with excitation via Xe arc lamp and dye-specific filter sets appropriate for the chosen 
chromophores. Ultimately, linear dynamic range and limits of detection will be 
determined using laser induced fluorescence measurements, reported literature values 
of existing displacement based sensors are 3 orders of magnitude and 1.0 pg/mL, 
respectively. 
In order to reduce the potential for false negatives and positives a multifaceted 
detection system would be incorporated. First, the analytes would be selected using a 
displacement immunoassay where antibodies directed toward the nitroaromatics would 
be covalently tethered to the surface of the microfluidic platforms forming stable capture 
beds used to selectively isolate the targets while confining these analytes to low 
nanoliter volumes effectively preconcentrating the analyte. The displacement process is 
shown in equations below in which the antibody (Ab) is bound to the fluorescently 
labeled antigen (Ag*). The binding affinity of the target has a binding affinity that is 
typically two orders of magnitude greater than that of the analogue thus in the presence 
of the target the antigen (Ag) displaces the analogue producing the means of signal 
transduction. 
fluorescence over time. Correlating the displaced fluorescently labeled analogues direct 
proportionality to the bound analyte thereby allowing for calibration based quantitation 
with broad linear dynamic range is possible in the displacement assay owing to binding 
more of the analyte at lower concentrations. In the displacement format, two forms of 
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quantification will be employed thereby providing both sensitivity and selectivity whereby 
the elimination of false readings can be reduced or eliminated. 
 Incorporation of high throughput microfluidic systems as the analysis platform offers 
high surface area to volume ratios which in turn allows for processing large sample 
sizes in short time periods. In conventional microfluidics sample injection volumes in the 
picoliter range are typical allowing for only a small amount of analyte to be processed 
resulting in lower overall signal to noise than could be realized were the sample size 
increased to the milliliter range and exhaustively interrogated prior to sensing. This 
mass sensitive approach to analyzing nitroaromatics would be analogous to “purge and 
trap” techniques employed by US EPA methods that involve chromatographic analyses 
of volatile organics. Using anti-TNT antibodies with high binding affinity to select and 
isolate more target from larger sample sizes provides the potential of unparalleled 
sensitivity especially when coupled to conductance based detection systems similar to 
those reported to achieve attomolar sensitivities of proteins on microfluidic platforms.12 
Ultimately, these analyses will take place submerged thus requiring a closed system 
capable of being isolated from an aqueous environment. The HTMSUs are closed 
systems that are not prone to leakage and when integrated are capable of withstanding 
significant outside pressure.13,14 
6.2.2 High Throughput Microsampling Unit. Microfabricated devices featuring high 
aspect ratio microstructures offer unparalleled throughput within high surface area to 
volume ratio conduits. This is particularly attractive when exhaustively interrogating 
large samples with low analyte concentrations for the purpose of quantitation is desired. 
The proposed microfluidic will incorporate multiple microfluidic channels to reduce the 
pressure drop across the device while allowing for high volume throughput over short 
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time periods. The advantage realized from this type of assay will be manifested in the 
preconcentration of many analyte molecules from approximately 1 mL samples as 
opposed to that of traditional microfluidics. For example, traditional microfluidics 
typically offers picoliter sample volumes, which when considering a sample that has 
nanomolar analyte concentrations reliable quantitation becomes increasingly prohibitive 
due to each picoliter only containing only a miniscule 602 molecules. Increasing the 
sampling efficiency allows for a dramatic increase in the number of analytes molecules 
available to for transduction at the detector thereby easing the restrictions on applicable 
detection strategies. 
 The proposed device will consist of a series parallel high-aspect ratio channels 
sharing common input/output ports. The devices will be replicated from a mold masters 
using hot embossing as described in detail elsewhere.15 Briefly, the substrate selected 
for the HTMSU is PMMA due to its high fidelity of forming structures with high-aspect 
ratios via micro-replication, minimal non-specific adsorption of biological components to 
its surface and its ability to generate functional surface-scaffolds through UV irradiation 
for the attachment of a variety of biological moieties.13,16 Initially, microstructures will be 
milled onto the surface of a brass plate with a high-precision micromilling machine 
(KERN MMP 2522, KERN Micro- und Feinwerktechnik GmbH & Co.KG; Germany) 
following our previously published procedures.15  
Using this technique three identical HTMSUs can be patterned onto the brass 
master enabling production of the polymeric units in triplicate during each hot 
embossing step. In order to accommodate the Pt electrodes used for the conductivity 
sensor and the inlet/outlet capillaries, the HTMSU was designed with multilevel 






analogous microfluidic’s detection zone was tapered to 80 µm from the 150 µm used in 
the cell selection beds and throughout the inlet region. The detection channel width was 
tapered from 100 µm to 50 µm over a 2.5 mm region beginning at the converged outlet 
and terminating 2.5 mm from the conductivity electrodes scaled for specific detection of 
CTCs. In the cell selection bed, channel widths (35 μm) that closely matched the 
average target cell diameter were used to increase the probability of cell-immobilized 
antibody encounters. In the proposed selection of TNT, initial experiments will be 
performed in 25 – 75 μm wide channels that are 150 μm deep to evaluate the effect of 
aspect ratio on the isolation and quantitation of TNT. To reduce the pressure drops 
when the device was operated at high volumetric flow rates, the HTMSU was designed 
with deep (150 μm), high-aspect ratio channels. For quantitation a conductivity detector 
was used. The sensitivity is governed by the cell constant (K) which is defined as L/A 
where L is the separation distance between the electrodes and A is the total surface 
area of the electrodes. The total conductance (G) is defined as: 
 
where C is concentration of the analyte, λ+ and λ- are limiting ionic conductance for the 
cations and anions, respectively. By establishing a baseline conductance for the run 
buffer the magnitude of perturbations of the baseline conductance in a given assay can 
be directly related to analyte concentration in the effluent. 
6.2.3 Surface Modification. Regio-specific ultraviolet (UV) modification of the PMMA 
substrate and cover plate is performed through an aluminum photomask to facilitate the 
formation of the carboxylated scaffold for directed antibody tethering exclusively within 
the cell selection beds of the HTMSU. Before final assembly via thermal fusion bonding, 





 antibody immobilization will be performed 
fluence for 10 min using a UV exposure station (ABM, Inc., San Jose, CA). Additionally, 
into the inlet/outlet ports of the device were inserted 237 μm OD and 150 μm ID 
polyimide-coated fused silica capillaries and the Pt electrodes fabricated with the 
required gap. After thermally annealing the cover plate to the substrate, a thin film of 
epoxy resin will be applied to the capillary-device interfaces to prevent leaks.  
Following UV modification of PMMA, the physicochemical properties of th
 effectively altered resulting in a moderate reduction of the glass transition 
temperature (Tg) at the cover plate-substrate interface. The resulting Tg allowed for 
efficient thermal fusion bonding at 101°C rather than the 106°C Tg of pristine PMMA,12,17 
which reduces potential thermal deformation of the high-aspect ratio microfeatures. 
Thermal fusion bonding will be performed using a temperature programmable ovensuc 
as that contained in gas chromatograph (Varian 3400, Palo Alto, CA) using the PMMA 
cover plate and the open-faced, hot embossed PMMA substrate. The substrate and 
cover plate will be aligned and clamped together between two borosilicate glass plates 
and the assembly placed into the temperature programmable oven of the GC, where the 
temperature will  be increased from 50°C to 101°C at a rate of 20°C/min. The 
temperature was held at 101°C for 15 min. 
6.2.4 Antibody Immobilization. Covalent
using a two step process. Initially, the UV-modified HTMSU device, following thermal 
assembly, will be loaded with a solution containing 4.0 mg/mL of 1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC), 6.0 mg/mL of N-
hydroxysuccinimide (NHS) in 150 mM 2-(4-morpholino)-ethane sulfonic acid at pH = 6 
(MES, Fisher Biotech, Fair Lawn, NJ) and buffered saline (Sigma-Aldrich, St. Louis, 
MO) for 1.0 hr to form the succinimidyl ester intermediate. The EDC/NHS solution will 
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onductivity Sensor. Conductivity electrodes will consist of Pt wires 
ents will be conducted in the run buffer where the critical 
com
then be hydrodynamically replaced with a 1.0 mg/mL anti-TNT antibody (Biological 
Detection Systems, Pittsburg, PA) solution contained in 150 mM PBS at pH = 7.4 
(Sigma-Aldrich, St Louis, MO) and allowed to react for 4 h after which the device will be 
rinsed with a solution of PBS (pH = 7.4) to remove any non-specifically bound moieties 
from the surface. 
6.2.5 Integrated C
(25 – 127 µm dia.) placed into guide channels of equal width and depth embossed 
orthogonal to the fluidic output channel. The Pt wires will be inserted into these guide 
channels prior to thermal assembly of the cover plate to the substrate. Once the wire is 
positioned, the substrate/wire assembly will be placed between glass plates and 
clamped together and finally, heated to a temperature slightly higher than the glass 
transition temperature of PMMA, once embedded the wire spanned the entire depth of 
the output channel. To break through the wire to form the electrode pair, a high 
precision micromilling machine (KERN MMP 2522, KERN Micro- und Feinwerktechnik 
GmbH & Co.KG; Germany) with a 50 μm bit was used. Following machining of the Pt 
wire and UV activation, the cover plate will be aligned to the embossed substrate via 
alignment marks and clamped together between two glass plates and subjected to 
thermal fusion bonding.    
Conductivity measurem
ponents are compatibility with the analyte and fluidic system. The releasing buffer 
will be carefully selected in large part for its relatively low conductivity (~50 µS/cm, pH 
7.2) and the addition of trypsin to digest the antibodies facilitating the removal of the 




.3 Expected Results and Significance 
nt based immunological measurements offers 
the recent literature on CTC isolation and enumeration in 
mic
6
 The current state of the art displaceme
at the optimum flow rate of 100 μL/min analysis times of 3 min using a single capillary 
with 0.55 mm i.d. that was 20 cm long.9-11,18 These experiments were characterized by 
less than ideal analyte recovery rates and deviations from linearity in quantitative 
measurements on samples above 300 ng/mL. Linearity in the previous schemes was 
limited to 2 to 3 orders of magnitude. Refining the isolation and release of the analytes 
for secondary measurements the linear dynamic range may be extendable. Tuning the 
microfluidics to capture the analytes more effectively and incorporating these features 
on a single chip it is possible to increase the sensitivity and limit of detection of the 
measurement systems while reducing the overall analysis time. For instance, if an 
HTMSU were employed with 50 parallel channels with matching cross section to those 
mentioned above the processing time for a 100 μL sample could be reduced 3 min to 
0.06 min. Incorporating high aspect ratio microchannels offers high surface area to 
volume ratios resulting in more exhaustive interrogation of samples leading to higher 
capture efficiencies. It stands to reason that if one extracts more of the analyte from the 
sample that the slope of the subsequent calibration curve would also increase thereby 
affording higher sensitivity.  
6.4 Dissertation Summary 
After a brief overview of 
rofluidic devices in Chapter 1, this dissertation initially focuses on the electrokinetic 
manipulation of biological cells within polymeric microfluidic devices in an effort to 
demonstrate the separation of mixed cellular populations. During my early work, I 
demonstrated that through manipulation of simple parameters such as solution ionic 
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ove upon some of the initial drawbacks of my early work, in 
Ch
for low abundant target cells without the need for sample pretreatment. 
strength, substrate surface chemistry, and the bulk composition of the substrate used 
that the apparent mobilities of cells in mixed populations could be exploited to effectively 
separate mixed populations of cells into its individual constituents. Also shown in my 
early work was the use of Rayleigh scatter to both distinguish cells based on size and 
as a means of direct quantitation. The basis for the enumeration and typing in the early 
work was that the larger particles or cells in suspension scattered more light than the 
smaller counterparts as indicated in Chapter 2. Though this work represented a 
significant stride in the community this work had a few drawbacks, primarily related to 
low throughput, incompatibility with densely populated samples, and enriched cells were 
of relatively low purity. 
In an effort to impr
apter 3 and 4, I expound on the development of a microfluidic device termed: high 
throughput microsampling unit (HTMSU), which simplified cell analysis greatly. The 
devices were micromanufactured with multilevel microstructures via a novel high 
precision micromilling technique developed in-house. The microstructures possessed 
aspect ratios greater than four and served to improve throughput by running identical 
channels in parallel. Further, the devices improved the sample interrogation by 
increasing the surface area to volume ratio by an order of magnitude, thereby exposing 
more of the sample to the capture elements improving the overall effectiveness of the 
protocol. Also within this device was a regiospecifically modified region which served to 
selectively isolate cells from suspension through an immunoaffinity based interaction 
between immobilized antibodies and membrane bound antigens expressed in the 
periphery of the target cells. These devices were used to analyze whole blood samples 
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to improve the 
turn
devices such as narrowing the channel widths, 
antibodies, and optimizing the processing velocity this 
tec
Finally, I transcended the confines of traditional disease related bioassays, and 
extended the technology to environmental samples in an effort 
around time, sensitivity, and portability of traditional groundwater assessment. As a 
model analyte E. coli was chosen due to its toxicity and its adverse impact on 
recreational waters in the form of beach closings due to elevated levels. The analysis of 
E. coli using HTMSUs continues to be a challenge due to many factors. The bacteria 
were much smaller than that of the cancer cells used in the proof of concept discussed 
in Chapter 3 and 4, hence capture efficiencies of no greater than 14% were obtained in 
initial experiments. Also, the conductivity sensor had to be modified in order to discern 
the smaller perturbations at the conductivity cell produced by the much smaller 
bacterium as it traversed the detector. In addition using brightfield microscopy the E. coli 
were difficult to distinguish when captured on microchannel walls even when 
fluorescently labeled because of the size and the relatively small depth of field when 
compared to the total channel depth. 
6.5 Immediate Projections 
With minor modifications to the 
changing the immobilized 
hnology will be widely applicable. Experimental optimization of the parameters will 
have significant impact on extending the applicability in disease diagnostics and 
prognostics. In the clinical setting, small relatively inexpensive devices with long shelf 
lives are required, and the advent of aptamers provide a basis for increased thermal 
stability with similar Kd values to antibodies directed towards the same target. Also, 
efforts are underway to facilitate the integration of molecular profiling techniques to the 
current devices that nondestructively isolate and enumerate the CTCs. By lysing the 
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cells, capturing the DNA via solid phase reversible immobilization, and performing on-
chip continuous flow polymerase chain reaction (cf-PCR) we will someday circumvent 
the current state of the art screening techniques such as colonoscopy, mammography, 
and magnetic resonance imaging.19,20 Further, in the environmental regime, 
investigation with these devices will yield assessment of environmental samples for low 
abundant bacterial cells, phytoplankton, and the devices will ultimately be used to trap 
and quantitate molecules as well as bacteria. Field deployability for environmental 
analysis and device shelf life will be improved by incorporating aptamers, small 
oligonucleotides that bind proteins with affinities that compare favorably with antibodies, 
because they are thermally stable and possess long shelf life. 
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